20465651

SOUTH-SOUTH TRADE PROMOTION PROGRAMME
PHILIPPINES
SUPPLY AND DEMAND SURVEY ON

PHARMACEUTICALS AND NATURAL PRODUCTS
May 2004
Supply and demand survey on pharmaceuticals and natural products Philippines
The designations employed and the presentation of the material in this document do not imply the
expression of any opinion whatsoever on the part of the International Trade Centre (ITC)
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries.
While every effort has been made to verify the information contained in this document, ITC
cannot accept any responsibility for any errors that it may contain.
This report has not been formally edited by the International Trade Centre (ITC).
- ii -
Table of content
Page
I.
Notes
iv
INTRODUCTION
A.
B.
C.
1
2
2
Product coverage
Objectives of the demand survey
Methodology
II.
SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS
III.
MAIN REPORT
A.
B.
C.
D.
E.
Market size
RPs distribution system
Market prospects
Regulatory environment
Useful addresses
9
15
16
18
23
- iii -
Page
List of tables
1.
2.
3.
4.
5.
6.
7.
8.
9.
RPs Top importers of pharmaceutical products (based on 2002 figures)

Countrys health expenditure share to Gross National Product from 1991 to
2000
Countrys health expenditure Per Capita
Governments fiscal allocation for health
2000 and 2001 regional distribution of pharmaceutical establishments
Consumer profile
Health and vital statistics
Ten leading causes of morbidity, number and crude rates 1992-1996 and
1998
Mortality: Ten leading causes, number and crude rates and percent of total
deaths 1997 and 1998 (Crude death rate per 100,000 population)
5
10
10
11
13
16
17
17
18
Annexes
I.
II.
III.
IV.
V.
VI.
VII
VIII.
IX.
X.
XI.
XII.
XIII.
XIV.
Product coverage for pharmaceutical products

Product coverage for natural products
Philippines top importers of pharmaceutical products
Price list of Presyong Tama, Gamot Pampamilya (right price for family med.)
Philippine imports of pharmaceutical products (1999-2003)
Philippine supplying countries of pharmaceutical products (1999-2003)
Philippine imports of natural products (1999-2003)
Philippine supplying countries of natural products (1999-2003)
Philippine exports of pharmaceutical products (1999-2003)
Philippine markets of pharmaceutical products (1999-2003)
Philippine exports of natural products (1999-2003)
Philippine exports markets of natural products (1999-2003)
Directory of Chamber of Filipino Drug manufacturers and distributors
Company/product profile forms
- iv -
27
33
37
43
49
59
63
69
71
77
81
85
89
99
NOTES
The following abbreviations are used:
BFAD
Bureau of Food and Drug
BOI
Board of Investment
BTRCP
Bureau of Trade Regulation and Consumer Protection
CFDMD
Chamber of Filipino Drug Manufacturers and Distributors, Inc.
CHIP, Inc.
Chamber of Herbal Industries of the Philippines
ITC
International Trade Centre
ITH
Income Tax Holiday
LDA
Developed Areas
OFW
Overseas Filipino Workers
OTCs
Over-The-Counter Drugs
PHAP
Pharmaceutical Healthcare Association of the Philippines, Inc.
PITAHC
Philippine Institute of Traditional and Alternative Health Care
PITC
Philippine International Trading Corporation
PNDF
Philippine National Drug Formulary
R&D
Research and Development
USP-NF
United States Pharmacopoeia / National Formulary
-v-
I. INTRODUCTION
The Philippine pharmaceutical industry is one of the vital sectors in the economy. As in all other
economies, there should always be an ample supply chain of drugs and medicines made available to
consumers in good quality and at reasonable and affordable prices. Through this, lives can be made
better or even saved.
The industry is engaged in the manufacture, distribution and wholesale and retail sales of medicines
and pharmaceutical specialties. The industry produces all forms of medicines and vaccines as, but
not limited to, tablets, capsules, powders/suspension, liquids, creams/ointments, fine liquid and
suppositories.
In the Philippine pharmaceutical industry, basic research in terms of extracting and producing raw
materials and chemicals from local sources is not present. While almost 90% of all drugs sold are
locally produced, the pharmaceuticals companies are mainly compounders, formulators and
packagers. Their establishments are engaged in the importation, repacking, marketing and
distribution of proprietary medicines and preparations.
As such investments along this activity are needed and being encouraged. As a support, the 2004
Investments Priority Projects of the Board of Investments (BOI), the manufacture of essential drugs
including herbal medicines and supplements, food supplements limited to the manufacture of
Vitamin A, iron and iodine and active substances of these drug has been included. This means
investments in these activities will enjoy incentive package under the BOI guidelines.
A. Product coverage
This demand survey covers all pharmaceutical import and export products (including active
ingredients, starting materials and formulations) classified under the heading 54 of the Philippine
Standard Classification Code and all import and export of natural products (including herbal
medicines). The complete product coverage is in Annex I for pharmaceutical products and Annex II
for natural and herbal products.
1.
Industry products and product classification
Products of the industry include all forms of medicines and vaccines that are useful in the
identification (diagnostic), prevention (prophylactic) and treatment (therapeutic) of illness or the
mitigation of disease symptoms.
The following are the classification of drug products:
Therapeutic class the more common therapeutic categories are analgesics, antacids,
antirheumatics, antibiotics, antidiarrheals, cardio-vascular preparations, cold/cough
preparations, dermatological preparations, vitamins/minerals and hypertensives.
Method of dispensing drug products are classified as either ethical (promoted only to
medical professionals and can be bought and sold only upon physicians prescription) or
proprietary (freely dispensed to the public and promoted over-the-counter).
-1-
Dosage form refers to the final form of a drug when it reaches the user. Examples are
syrups, injectibles, ointments, capsules, pills, tablets, powders, lozenges, solutions,
suspensions, mixtures, tinctures, elixirs, extracts, fluid extracts, emulsions, lotions, sprays,
aerosols and suppositories.
Dosage strength maybe purchased in various dosage strengths with the specific needs of
the patients.
Sources of basic raw materials maybe classified as synthetic-based, plant-derived, animalderived, vaccines and antibiotics and related fermented medicinal products.
B. Objectives of the demand survey

The survey is intended to pursue the following objectives:
To give an overview of the Philippine pharmaceutical and natural products market by

presenting the import profiles vis--vis supply capabilities of the local industries.
To identify products under these sectors with high import potentials with sources of imports.
To identify companies which could be targeted as potential importers/buyers.
To identify companies which could targeted as potential suppliers especially in the natural /
herbal sector.
C. Methodology
In preparing this survey the methodology utilized is as follows:
1. Desk research on:
Qualitative industry data using past studies and existing reports.
Statistical data on Philippine imports of pharmaceutical and natural products for the last five
(5) years.
Statistical data on Philippine exports of pharmaceutical and natural products for the last five
(5) years.
Existing data of the National Statistics Office, Bureau of Food and Drugs, Department of
Health, Bureau of Import Services, Board of Investments, and Bureau of Export Trade
Promotion, all of the Department of Trade and Industry.
2. Field Research:
Interviews with industry players and industry experts
Updating of companies contact information by telephone
-2-
II.
SUMMARY OF CONCLUSIONS AND

RECOMMENDATIONS
The Philippine pharmaceutical industry cannot be considered a true drug industry since basic
research in terms of extracting and producing raw materials and chemicals from local sources is
absent. Most local drug firms are thus confined to: importing raw materials and finished goods in
bulk, formulating and processing these into various dosage forms, packaging finished products and
distributing drugs to drugstores, physicians, hospitals and other retailers.
Basic drug chemicals are not manufactured locally and about 80% to 90% of the raw materials of
the industry is imported, a situation which has persisted for the last few decades. Only minor
components such as sugar, flour, cornstarch, alcohol, glucose and glycerin are locally produced.
Aside from medicinal products, there are other imports, such as packaging materials, used by the
drug industry, which have added to high import costs. Imported packaging materials include
specialized items such as aluminum tubes and vial caps, glass vials, rubber droppers, intravenous
solution bottles, and ampoules. Only packaging materials such as bottle caps, foils and blister foils
are produced locally.
In view of this situation, prospective investors are being encouraged in the aforementioned areas to
enable the industry to be self-sufficient. Under the governments 2004 Investments Priorities Plan
(IPP), firms engaged in the manufacture of essential drugs (including herbal medicine and
supplements) listed in the current Philippine National Drug Formulary (PNDF) and active
substances of drugs are qualified to avail of fiscal and non-fiscal incentives as follows:
1. Fiscal incentives
Income Tax Holiday (ITH) a BOI-registered enterprise shall be exempt from the payment
of income taxes reckoned from the scheduled start of commercial operations as follows:
-
New projects with pioneer status

New projects with non-pioneer status
Expansion projects
New/expansion projects in Less
Developed Areas (LDA), regardless of status
six (6) years

four (4) years
three (3) years
six (6) years
Tax deduction for labor expense;
Exemption from wharfage dues and export tax, duty, import and fees;
Tax credit on raw materials and supplies.
2. Non-fiscal incentives
Employment of foreign nationals;
Simplification of custom procedures;
Importation of consigned equipment; and
Operation of bonded manufacturing/trading warehouse.
-3-

The Philippine pharmaceutical industry is controlled by a few transnationals, that 68% of the
pharmaceutical market belongs to these foreign companies with the remaining 32% shared by
Filipino enterprises with foreign investors.
The size of the local pharmaceutical market could be measured by sales to trade outlets. In 2003,
sales to trade outlets reached Php 72.4 billion or US$ 1.45 billion and the local market posted an
average of 10% annual growth.
To better understand the demand of pharmaceuticals, it is necessary to study the interplay between
the pharmaceutical industry and its market.
From the viewpoint of the industry, sales are determined by the following factors:
The economys performance in terms of Gross National Product and purchasing power, and
the resultant family and institutional budgets made available for medical care, including
pharmaceuticals;
The size of the population and its rate of growth, as well as disease incidence which
determine requirements for drug therapy;
The governments priorities and fiscal allocations for health, which define the level of
pharmaceutical sales to the public sector.
From the viewpoint of the market, the nature of the demands differ among the proprietary and
ethical segments:
Proprietary drugs are similar to consumer items in terms of the dynamics of demand. Endusers suffering from ailments not requiring professional medical care recognize their
condition (e.g. cough or cold), then purchase the proprietary products deemed most
appropriate.
The demand for prescription medicines is markedly different as it is not end-users but
medical professionals who decide on the choice of drug therapy. To comply with the
Generic Act of 1988, the physician provides the patient with a prescription containing a
drugs generic name and if desired, a recommended brand name. The pharmacist must
dispense according to the physicians prescription with regard to generic name. The patient,
is however, free to choose among various brand names with the same generic name or active
ingredient.
The Generics Act of 1988, an act to promote, require and ensure the production of an adequate
supply, distribution, use and acceptance of drugs and medicines identified by their generic names,
exerts a competitive influence between higher-priced branded drugs and lower-priced generic
products with the aim of lowering drug prices. However, there is still no marked evidence of
increased market share of generic drugs. Its share has constantly been placed at 8% notwithstanding
the 10% average growth of the total pharmaceutical market. The main reason cited is the perception
that lower prices may mean lower efficacy.
-4-
The countrys top 20 importers of pharmaceutical products are important business leads. The listing
on the countrys top importers of pharmaceutical products was generated using year 2002 data of
the Bureau of Import Services, Department of Trade and Industry and is presented in Table I below.
These companies could be potential buyers for pharmaceutical products. Contact information on
these companies and other top importers are provided somewhere in this report. (Annex III)
Table 1. RPs Top importers of pharmaceutical products (based on 2002 figures)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
NOVARTIS Healthcare Phils.

PFIZER Inc.
GLAXO Smithkline Phils. Inc.
VITACHEM Industries
ASTRAZENECA Pharmaceutical (Philippines), Inc.
UNITED LABORATORIES, INC.
ROCHE (Philippines), Inc.
BASF Philippines, Inc.
BOEHRINGER Ingelheim (Philippines), Inc.
BAYER Philippines, Inc.
SANOFI-Synthelabo
SCHERING-PLOUGH Corporation
MERCK SHARP and DOHME Philippines
BRISTOL MYERS SQUIBB Philippines, Inc.
ZUELLIG Pharma Corporation
SERVIER Philippines, Inc.
ABBOTT Laboratories Philippines
MERIAL Philippines Inc.
AVENTIS Pharma, Inc.
WYETH Philippines
Philippine importers of pharmaceutical products and/or active raw materials generally prefer
sourcing from Europe and USA as some of them have had experiences of fluctuating quality levels
from other sources.
The Philippine International Trading Corporation (PITC), the trading arm of the government is
another potential buyer. PITC is presently importing mainly from India, pharmaceutical products
under the following therapeutic categories:
-
Anti-bacterials
Anti-hypertensives
Non-steroidal anti-inflammatory drugs
Oral hypoglycemic/anti-diabetes agents
Anti-anginal agents
Anti-cholesterol agents
Bronchodilators
Anti-diarrheals
Anti-psychotics
Anti-epileptics
The pharmaceutical products are for most common ailments and diseases in the country. The prime
consideration is lower cost. The price list is in Annex IV for guidance of prospective suppliers.
-5-
Competition in the drug market is intense and dynamic and this is best seen in the large number of
competitors carrying various brand names and product lines.
Prices of pharmaceutical products in the Philippines are generally higher by as much as ten (10)
times, higher than in other Asian countries next to Japan. A significant factor contributing to the
generally high drug prices is the import-dependent nature of the industry. Another factor is due to
industrys dependence on marketing, advertising and promotions as tools to ensure steady sales.
Suppliers wishing to enter the Philippine market need to be able to prove quality at competitive
prices to gain considerable success. The easiest and fastest way to penetrate the market is through
acquiring a local partner who is already active in the industry. This partner has familiarity in
handling all aspects of the business. The Directory of Chamber of Filipino Drug Manufacturers and
Distributors presented somewhere in the report would be useful in finding local partners when
necessary.
Mercury Drug Stores is the largest pharmaceutical chain in the Philippines with about half or 50%
of the overall pharmacy business. The drug store could be contacted at this address:
Mercury Ave., cor E. Rodriguez Jr.
Bagumbayan 1110 Quezon City
Telephone No. : (632) 911.5071
Fax No.
: (632) 911.6673
Email address : info@mercurydrug.com
Website
: www.mercurydrug.com
Since the country is an archipelago, it is uneconomical and inefficient for most pharmaceutical
companies to distribute their products. Only a limited number of companies have their own
distribution network, the rest avails of the service of the professional distributors.
The pharmaceutical industry is profitable since there is very little price elasticity associated with
price increases. A patient will not change the demand for a product with a small change in price
when there are no close or available substitutes.
The long-term outlook is promising since demand for medicines and drugs is interdependent on the
demographics of the countrys population. The growth of the population (81.1 million in 2003) at
an annual average of 2.36% will surely cause an increased demand for drugs, along with the
prevalence of communicable and infectious diseases and the rising incidence of degenerative
diseases.
There is an emerging local market for herbal medicines/ food supplements. Initial estimate from the
industry players of the local market size is placed at US$ 40 million. The market is expected to
grow dramatically in the coming years. People take herbal medicines for a number of reasons: faith
in tradition, fear of artificial chemicals and attraction to anything that is billed as natural.
At present, imported herbal supplements proliferated and sold at mostly high prices in health shops.
Reported local sales from herbal are estimated to be from PhP 17 million in 2000 to PhP 27 million
in 2002. Annual average sales growth was from 30% to 70%. 1
1
Figures were given by industry players
-6-
The factors which are expected to contribute to the dramatic growth of the natural / herbal remedies
are:
The increase in ageing population, trend towards self-medication, emergence of unknown

diseases and allergies due to widespread use of synthetic drugs and biotech products;
increasing health consciousness of the population.
The rising health costs and more focus on disease prevention rather than cure.
The growing healthy lifestyle and the consumer demand for all natural products as a way of
life.
The growing consciousness for environment-friendly products.
The most common and lately most demanded herbal medicine/supplement product which is
produced locally is Ampalaya (Momordica Charantia) which the current sales is estimated at PhP5
million a day or translated to PhP 1.8 billion a year. This is attributed to its effectiveness for
lowering blood sugar. Some ampalaya products which are mixed with other herbals are sold in
capsules (crude extracts) and tea.
The other most common herbal personal care product is the Papaya ( Carica Papaya) based skin
whitening soap which is being sold by different companies. The skin whitening soap category is
worth at least PhP2 Billion a year and Filipinos buy as many as 200 million pieces a year. Again
this is attributed to the effectiveness of the herbal products and partly since many Filipinos wanted
to look fairer or white.
The Philippines has the potential to develop into one of the worlds largest growers of medicinal
plants, given the countrys rich biodiversity and long tradition of use and intimate knowledge of
herbal medicine. Five (5) percent of the worlds plant species can be found in the country. There are
13,500 plant species where 3,500 species are endemic. Around 1,500 were identified as medicinal
plants. 850 medicinal plants were discussed in a book, Medicinal Plants of the Philippines by
Dr. Eduardo Quisumbing (reprinted in 1978) and more than 200 medicinal plants with identified
phytochemical in a book, Philippines Medicinal Plants in Common Use: Their Phytochemistry and
Pharmacology (Michael L. Tan / AKAP 1980)
Only 120 medicinal plants have been scientifically validated for safety and efficacy of which 10
medicinal plants have been promoted by the Department of Health. The ten (10) are as follows:
Lagundi (Vetex Negundo) for asthma, coughs and colds;

Yerba Buena (Mentha Cordifolia) for body aches;
Sambong (Blumea Balsamifera) for dissolving urinary tract stones;
Tsaang Gubat (Ehnetia Microphylla) for stomach aches and diarrhea;
Niyug-niyogan (Qusiqualis Indica) ascaris antihelminthic;
Bayabas (Psidium Guajava) astringent;
Akapulko )Cassia Alata) antifungal;
Ulasimang Bato (Peperonia Pellucida) for gout and lowering blood uric acid;
Bawang (Allium Sativa) for lowering blood cholesterol;
Ampalaya (Momordica Charantia) for lowering blood sugar.
-7-

Of these ten (10), only 4 are available in commercial formulation namely Lagundi, Sambong,
Akapulko and Ampalaya. Two medicinal plants Tsaang Gubat and Yerba Buena have also received
regulatory approval.
The absence of the technology is a hindrance to the export potential of well-researched and proven
herbal medicines. Research and development (R&D) has not caught up with the pace that the local
pharmaceutical industry needs. Governments support to R&D is almost nil.
The natural and herbal products are exported to countries with large concentration of Overseas
Filipino Workers (OFW) through regular channels. The products have not reached the mainstream
markets for the simple reason that promotion of the products has been limited to the domestic
market.
-8-
III. MAIN REPORT

A. Market size
1. Domestic industry
The Philippine pharmaceutical market as indicated by sales to trade outlets amounted to Php 72.4
billion or approximately US$ 1.45 billion in 2003. The local market registered an estimated annual
growth of 10% in sales. However, due to the countrys high poverty threshold coupled with
escalating population growth of about 2.4 percent annually and the meager annual health budget,
placed the life saving commodity beyond the reach of many Filipinos because of its high cost and
inequitable distribution. To address the heavy burden of high medicine prices on the Filipino
consumers, the Philippine government under President Gloria Macapagal-Arroyo has directed the
implementation of a program that will improve public access to quality healthcare. The program is
called, Presyong Tama, Gamot Pampamilya (Right Price for Family Medicines) Program. The
program involves the importation of widely recognized, off patent branded medicines, which are
usually prescribed for the most common ailments and diseases. The medicines shall be made
available to Filipino consumers at very affordable prices. Studies showed that prices of medicines in
the Philippines are as much as ten (10) times higher that in other Asian countries next only to Japan.
When the program began in 2000, there were seven (7) brands available in the countrys
Department of Health retained hospitals nationwide. Today, this range has been expanded to a total
of 25 brands from the following therapeutic categories: antibacterials, anti-hypertensives, nonsteroidal, anti-inflammatory drugs, oral hypoglycemic/ anti-diabetes agents, anti-anginal agents,
anti-cholesterol agents, bronchodilators, anti-motility agents/ anti-diarrheals, anti-psychoticsand
anti-epileptics.
Medicines sold are from 27% to 87% cheaper compared to those sold in local drug stores, yet these
are not subsidized prices.
Medicines are sourced only from original manufacturers/multinational subsidiaries or authorized
licensees and are of the same quality and efficacy as the higher-priced counterparts sold in local
drugstores.
The importation of these medicines is made by the Philippine International Trading Corporation, a
government trading company.
2. Apparent consumption
The tables below will provide the reader an estimation of past and future demands for
pharmaceutical products.
-9-
Table 2. Countrys health expenditure share to Gross National Product from 1991 to 2000
STATISTICS
Total Health
Expenditure (in
million pesos) at
current prices
GNP at Current
Prices (in billion
pesos)
Share of Health
Expenditure to
GNP (%)
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
Average
Annual
Growth
Rate
35.9
39.6
47.4
54.6
65.2
76.2
87.1
95.7
108.3
113.5
13.7
1,254.6
1,374.8
1,500.3
1,736.4
1,958.6
2,261.3
2,528.3
2,815.3
3,155.6
3,491.1
12.0
2.86
2.88
3.16
3.14
3.33
3.37
3.44
3.40
3.43
3.25
Source : National Statistical Coordination Board
Table 3. Countrys health expenditure Per Capita
STATISTICS
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
Average
Annual
Growth
Rate
Health
Expenditure Per
Capita (in pesos
at current prices)
575
621
725
817
954
1,089
1,217
1,308
1,449
1,486
11.1
Health
Expenditure Per
Capita (in pesos
at 1985 prices)
334
332
363
378
408
427
451
441
459
451
3.4
Population (M)
62.4
63.8
65.3
66.8
68.3
70.0
71.5
73.1
74.7
76.3
2.3
10.4
19.6
15.3
19.4
16.9
14.3
9.9
13.2
9.7
13.7
2.3
2.3
2.3
2.2
2.2
2.1
2.3
Total Health
Expenditure
Growth Rate (%)
Population
2.2
2.4
2.3
Growth Rate (%)
- 10 -
Table 4. Governments fiscal allocation for health

Source of Funds
Percent Share
1991
1992
1993
1994
1995
1996
1997
1998
1999
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
Government
National
Local
38.51
34.66
3.85
43.17
38.80
4.37
36.60
24.07
12.53
37.21
21.26
15.95
35.33
19.33
16.00
36.30
19.93
16.37
38.30
20.52
17.78
38.66
20.53
18.13
37.91
20.04
17.87
Social Insurance
Medicare
Employee
5.44
5.17
0.27
5.97
5.71
0.26
6.37
6.07
0.30
5.71
5.37
0.34
4.53
4.25
0.28
5.06
4.79
0.27
5.13
4.87
0.26
3.73
3.46
0.27
4.86
4.61
0.25
Private Source
Out-of-pocket
Private Insurance
HMOs
Employer
Private
56.05
47.69
2.88
1.25
3.41
0.82
58.85
49.58
2.83
1.31
4.18
0.95
57.03
47.75
2.41
1.42
4.53
0.92
57.06
47.47
2.09
1.64
4.89
0.97
60.13
50.43
1.77
1.98
4.98
0.97
58.64
48.71
1.68
2.28
5.06
0.91
56.58
46.88
1.94
2.50
4.42
0.84
57.62
47.96
1.98
2.88
3.95
0.85
57.24
46.26
2.14
3.84
4.01
0.99
All Sources
3. Industry players
Industry players in the pharmaceutical industry are classified into two (2), to wit:
(a) Drug establishments
Companies engaged in the manufacture, importation, re-packing and distribution of drugs and
medicines.
Manufacturers
-
Technically, these are formulators, who formulate from imported active raw
materials according to a specific recipe
They manufacture their own products.
Toll Manufacturers
-
Technically, these are formulators, they formulate from imported active raw
materials according to a specific recipe.
They manufacture for third party companies or traders.
- 11 -
Traders
-
They are registered owners of drug products.
They supply the raw materials and packaging components and provide products
monographs, quality control standards and procedures.
They subcontract the manufacture of such products to licensed manufacturers.
Importers
-
Import raw materials, active ingredients and/or finished products for their own use
for wholesale distribution to other pharmaceutical establishments and outlets.
Distributors
-
For a fee they distribute other companies products nationwide.
They also act as agents of some small foreign companies.
(b) Drug outlets

Drug stores, pharmacies, and other establishments that sell drugs and medicines at retail level or
dispense medicines for direct use of consumers.
Drugstores, Pharmacies, Boticas including Hospital Pharmacies these are drug outlets
where registered drugs, chemical products, active principles, proprietary medicines or
pharmaceutical specialties and dental medicines, or veterinary preparations are compounded
and/or dispensed.
Retail Outlets for Non-prescription drugs these includes non-traditional outlets such as
supermarket and stores, drug outlets where registered non-prescription or over-the-counter
(OTC) drugs are sold in their original packages, bottle or containers or in small original
containers.
4. Regional distribution of pharmaceutical establishments

Table 5 below shows the number of companies registered by the Bureau of Food and Drugs
(BFAD) and their regional distribution.
- 12 -
Table 5. 2000 and 2001 regional distribution of pharmaceutical establishments

REGION
NCR
CAR
I. Ilocos Region
II. Central Valley
III. Central Luzon
IV. Southern Tagalog
V. Bicol Region
VI. Western Visayas
VII. Central Visayas
VIII. Eastern Visayas
IX. Western Mindanao
X. Northern Mindanao
XI. Southern Mindanao
XII. Central Minadanao
CARAGA
Total
2000 DRUG
ESTABLISHMENTS
2001 DRUG
ESTABLISHMENTS
Drug
Manufacturers
Drug Traders
Drug
Manufacturers
Drug Traders
123
0
4
1
17
34
1
7
18
2
2
3
10
1
2
225
348
2
2
1
7
24
0
5
5
0
5
1
0
0
0
400
113
0
4
1
19
35
1
9
20
2
2
3
10
1
2
222
314
2
2
1
7
24
0
4
5
0
5
2
0
0
0
366
The concentration of drug manufacturers was in Metro Manila with 51% of the 222 drug
manufacturers registered in 2001. The concentration is higher among drug traders of which 86%
was in Metro Manila from the 366 registered drug traders.
5. RPs imports of pharmaceutical products
Bulk of the importations of the pharmaceutical industry is mainly composed of medicinal and
pharmaceutical products for retail sale. This composed more than 50% of the total importations.
The rest of the importations are chemicals, semi-finished products and other raw materials for the
manufacture of drugs and pharmaceuticals for all types of ailments and diseases..
Imports grew at 2.1% from the years 1999 to 2003. The countrys pharmaceutical imports totaled to
US$ 362.1 million in 1999 and reached US$ 388.8 million in 2003. Imports of pharmaceutical
products constituted a mere .98% of the countrys total imports from around the world in 2003.
(Please refer to Annex V for details)
6. RPs supplying countries of pharmaceutical products
Major suppliers of pharmaceutical products in 2003 are Switzerland (11.6% share), Germany (9.9%
share), France (9.3% share), United Kingdom (8.4% share), Australia (8.3% share) and USA (6.0%
share). These countries are the centers of medicinal research and manufacture and the home bases
of multinational pharmaceutical firms operating in the country. (Please refer to VI for details)
- 13 -
7. RPs imports of natural products

Imports of natural products registered an average growth rate of 3.43% during the five-year period
1999 to 2003. Imports were valued at US$ 34.9 million in 1999 and grew to US$ 39.4 million in
2003.
The biggest import was hydrogenated vegetable fats which accounted for 16.8% of the countrys
total imports. This was followed by carrageenan (10.8%); seaweeds and other algae (9.4%) and
natural gum and gum resins (8.3%). (Annex VII gives more details)
8. RPs supplying countries of natural products
Major suppliers of natural products in 2003 were USA which accounted for (21.1%); Malaysia
(17.5%), Indonesia (9.9%), Denmark (9.3%), and Singapore (8.8%). (Other supplying countries are
presented in Annex VIII)
9. RPs Exports of pharmaceutical products
The countrys exports of pharmaceutical products achieved a negative growth rate of 2.2% during
the period 1999 to 2003. Exports in 1999 were valued at US$ 19.4 million and dropped to US$ 17.5
million in 2003. Bulk of the pharmaceutical exports was composed mainly of medicines and
pharmaceutical products for retail sale, which accounted for over 70% of the total exports in 2003.
(Please refer to Annex IX)
10. RPs export markets of pharmaceutical products
Major export markets for the countrys pharmaceutical exports are Vietnam (accounting for 14.8%),
Australia (12.3%), Malaysia (10.2%), Thailand (8.4%), and Myanmar (8.4%). Most of the markets
are neighboring Asian countries. (Please refer to Annex X)
11. RPs Exports of natural products
Exports of natural products, on the other hand, posted an average growth rate of 10.4% over the
period 1999 to 2003. Exports in 1999 totalled to US$438.6 million and increased to US$ 598.2
million in 2003. Exports were made up mostly of coconut/copra oil crude and refined that
accounted for a combined 84.4%. Another important export is carrageenan and seaweeds for a
combined 13.4%. (Please refer to Annex XI)
12. RPs export markets of natural products
These natural products were exported mostly to the Netherlands that absorbed 32.9% of the
countrys total exports. This was followed by USA (30.6%), Malaysia (7.5%), PR China (5.4%) and
Japan (4.6%). (Please refer to Annex XII for more details)
- 14 -
B.
RPs distribution system
The diagram below illustrates how the pharmaceutical products distribution system works.
Distribution System of Pharmaceutical

Products
I.
MULTINATIONAL COMPANIES (MNC)
Mother companies /
Foreign Suppliers o
raw materials
II
Domestic
Formulators: own or
toll formulators
Marketing Dept of
companies w/
formulation facilities
MKTG
PROMO
Drug Dept Trader:

Companies w/o
Third Party
Distribution
Drugstores
Hospitals
Clinics
MDs
CONSUMERS
Drugstores
Hospitals
Clinics
MDs
CONSUMERS
NATIONAL COMPANIES (NC)
Foreign Suppliers o
raw materials
II
Marketing Dept of
companies w/
Domestic
Formulators:
own products
toll formulator
Drug Dept Trader:

Companies w/o
Own
Distribution
Third Party
Distribution
IMPORTERS OF FINISHED PRODUCTS
Suppliers
MNC: Mother
Companies
1.
2.
Domestic Companies
MNC:
NC
1.
MNC Scheme
2.
NC Scheme
Distribution network of natural / Herbal products.
Natural / Herbal companies distribute their products through finding partners, exclusive
distributorships or otherwise
Some companies distribute products directly to drugstores, supermarkets/groceries
- 15 -
Some companies distribute products directly through their own shops/outlets
In terms of market reach, companies distribute on a national and regional level as well
C.
Market prospects
1. Consumer profile (Table 6)

INCOME AND EXPENDITURE
(At current prices)
2000
Annual average family income (PhP)

Annual average family expenditure (PhP)
Annual average family saving (PhP)
POPULATION
144,039
118,002
26,037
2000
Total
Male
Female
0-14 years
15-64 years
65 years and over
Sex ratio
Density (persons per square kilometer)
Growth rate
Average household size
76,504,077
38,524,266
37,979,811
37.0%
59.2%
3.8%
101.4
255
2.4%
5.0
2005
Population projection (medium assumption)
84,241,341
1997
123,168
99,537
23,61
1995
68,616,536
37,979,811
34,032,366
38.4%
58.1%
3.5%
101.6
229
2.3%
5.1
2004
82,663,561
1994
83,161
67,661
15,500
1990
60,703,206
30,538,285
30,164,921
39.6%
57.0%
3.4%
101.2
202
2.4%
5.3
2003
81,081,457
Source: National Statistics Office
2. State of health
Tables 7 to 9 provide information regarding the state of health of the Filipinos. This will serve as
guide to determine the types and kinds of pharmaceutical/medicines with big potential.
- 16 -

Table 7. Health and vital statistics
Births
Male
Female
Marriages
Death
Male
Female
2000
1999
1998
1,766,440
1,613,335
1,632,859
918,243
840,528
853,304
848,197
772,807
779,555
577,387
551,445
549,265
366,931
347,989
352,992
217,404
207,610
210,592
149,527
140,379
142,400
2005
Crude birth rate (per thousand population)
Crude deathe rate (per thousand population)
Crude rate of natural increase (per thousand pop.)
Total fertility rate (number of children per woman)
Life expectancy at birth ( in years)
Male
Female
2004
24.63
24.09
2003
25.16
5.60
5.66
5.72
18.49
18.97
19.45
3.00
3.08
3.15
67.83
67.53
67.23
73.08
72.78
72.48
Source: National Statistics Office
Table 8. Ten leading causes of morbidity, number and crude rates - 1992 1996 and 1998
(Rate per 100,000 population)
Leading Causes of
Morbidity
5-Year Average
(1992-1996)
1997
Number
1998
Number
Rate
Rate
Number
Rate
1,124,395
1,693.8
899,409
1,257.0
931,655
1,273.7
Diarrheal Diseases
Pneumonias
565,687
851.7
672,681
940.2
646,789
884.2
Bronchitis
890,972
1,341.7
637,905
891.6
635,089
868.2
Influenza
654,496
9,585.1
574,748
803.3
563,674
770.6
Tuberculosis, all forms
149,963
225.1
240,509
336.1
151,650
207.3
Malaria
55,815
83.9
69,248
96.8
72,309
98.9
Chicken pox
59,109
88.9
64,085
89.5
70,589
96.9
Diseases of the heart
103,600
156.1
63,794
89.2
44,532
60.9
Measles
Dengue / Dengue HFever
51,548
77.1
37,857
52.9
32,613
44.6
16,405
24.5
13,290
18.6
23,591
32.3
10
Source : Department of Health
- 17 -

Table 9. Mortality: Ten leading causes, number and crude death rates and percent of total
deaths - 1997 and 1998 (Crude death rate per 100,000 population)
1997
Causes
Number
Rate
1998
Percent
of
Number
Total
Deaths
Rate
Percent
of
Total
Deaths
1.
Diseases of the circulatory system
72,250
101.0
21.3
55,830
76.3
15.8
2.
Diseases of the respiratory system
50,160
70.1
14.8
41,380
56.6
11.7
3.
Accidents
28,563
39.9
8.4
33,709
46.1
9.5
4.
Malignant neoplasms
26,842
37.5
7.9
32,090
43.9
9.1
5.
Tubercolosis, all forms
23,056
32.2
6.8
29,874
40.8
8.5
6.
7.
Diabetes Mellitus
Nephritis, Nephrotic Syndrome and
Nephrosis
Respiratory condition of foetus and
new born
6,749
9.4
2.0
28,041
38.3
7.9
6,704
9.4
2.0
14,228
19.5
4.0
5,578
7.8
1.6
8,819
12.1
2.5
9.
Congenital anomalies
4,912
6.9
1.4
7,516
10.3
2.1
10.
Septicemia
4,417
6.2
1.3
7,453
10.2
2.1
8.
Source: Department of Health
D. Regulatory environment
1. Product registration
The Department of Health through its Bureau of Food and Drugs (BFAD) is the regulatory body
that governs the industry to insure safe, effective and quality pharmaceutical drugs to the market.
All establishments engaged in the manufacture, importation or distribution of drugs must apply for
a License to Operate (LTO) issued by BFAD. Other specific requirements depending on the type of
activity to be undertaken are summarized below:
CHECKLIST OF REQUIREMENTS FOR REGISTRATION OF
PHARMACEUTICAL PRODUCTS
REQUIREMENTS
1. Letter of application and Accomplish Form No. 8 (Application
for registration of Pharmaceutical Product)
2. Suggested Retail Price (as per AO#48-C s. 1999)
- 18 -
TYPE OF APPLICATION
INITIAL
RENEWAL
REQUIREMENTS
3. Copy of valid agreement between manufacturer and trader,
distributor / importer / exporter
4. Unit dose and batch formulation
5. Technical specifications of finished product
6. Certificate of analysis of active raw materials
7. Certificate of analysis of finished product
8. Technical specifications of finished product
9. Full description of the methods used, the facilities and controls
in the manufacture, processing and packaging of the product
10. Details of the assay and other test procedures for finished
product including data analysis
11. Detailed report of stability studies to justify claimed shelf life
(accelerated or long term) 3 batches
12. Representative sample in market or commercial presentation.
13. Unattached generic labeling materials, label, box, insert,
blister / strip oil
14. For imported product:
Certificates of free sale from country of origin
Government certificate attesting to the status of the
manufacture as to competency, reliability of personnel and
facilities
Both should be authenticated by territorial Philippine
consulate
15. For product in plastic container:
15.1 Studies done on the plastic to substantiate claim that
product is safe to use:
Components of the plastic used
Chemical Test
Physical tests
Biological tests (cell toxicity, tissue implantation,
etc.) for parenteral and ophthalmic preparations.
15.2 Methodology on how different tests were conducted
and include limits (results) of each test.
15.3 Empty plastic containers and closures
16. For New Drug (if applicable)
Pre-clinical studies
Clinical studies (Phase I, II and III)
Protocol for monitored release.
17. Certificate of approval of PMS (if applicable)
18. Bioavailability / bioequivalence studies (for Rifampicin
products)
19. Dissolution profile for drug product under List B (B Prime)
20. Copy of latest Certificate of Product Registration (CPR)
- 19 -
TYPE OF APPLICATION
INITIAL
RENEWAL
CHECKLIST OF REQUIREMENTS FOR

DRUG DISTRIBUTOR
1. Accomplished Notarized Petition Form / Joint Affidavit of Undertaking
2. List of products identified by generic names and brand names, to be distributed
3. Reference Materials:
Philippine National Drug Formulary
R.A. 3720 Foods, Drugs & Devices & Cosmetics Act
R.A. 6675 Generics Act of 1988 and relevant implementing rules and regulations
R.A. 5921, Pharmacy Law as amended and relevant implementing rules and regulations
R.A. 8203, Special Law on Counterfeit Drugs and its implementing rules and regulations
Any one of the following reference books:
United States Pharmacopoeia / National Formulary (USP-NF) latest edition
Remingtons Pharmaceutical Sciences (latest edition)
Goodman & Gilman Pharmacological Basis of Therapeutics (latest edition)
4. Batch Distribution Record Book
5. Copies of Pharmcists Registration Certificate, PRC-ID, valid PRT, ID picture, Duties and
Responsibilities, Certificate of Attendance of owner/pharmacist to a BFAD seminar on
Licensing of Drug Establishments and outlets
6. Location Plan / Floor Plan (Office & Storage Room) with dimensions
Photocopies of the following:
If Corporation, Registration with SEC and Articles of Incorporation or Partnership
If Single Proprietorship, Certificate of Business Name Registration with the Bureau of Trade
Regulation and Consumer Protection (BTRCP)
Contract of Lease for the space of the office and storage if the applicant does not own the building
If Importer:
Foreign Agency Agreement from each supplier duly authenticated by the Territorial
Philippine Consulate
Certificate of Registration of manufacturer and its conformity with GMP from Health
Authority (for finished products only)
If Wholesaler:
A Valid contract with BFAD licensed supplier / manufacturer
Certificate that the products it sells are registered with BFAD
LTO of manufacturer
If Exporter:
A valid contract with BFAD licensed supplier / manufacturer
Certification that the product it sell are registered with BFAD
LTO of manufacturer
- 20 -

2.
Product labelling
BFAD sets specific standards and requirements for pharmaceutical firms to comply in labeling their
products in order to have a clear presentation of the products minus fraudulent and misleading
representations.
In all cases, the generic name shall be the prominently printed element on the label, defined as the
one with the highest point size among the various printed elements in the label. Information must
include
Generic name of a particular pharmaceutical must appear above its brand name on all packaging
Registered trade or brand name;
Duly registered trademark;
Duly registered business name;
Philippine address of the manufacturer, importer or repacker of the consumer product;
General make or active ingredients;
Net quantity of contents, in metric terms of weight, measure or numerical count;
Country of manufacture, if imported; and
Statement that the consumer product is manufactured, refilled or repacked under license from a
principal, if applicable.
Directions for use;
Warning toxicity;
3. Import duties
As of January 1, 2003, all pharmaceutical products except those under the headings 29.36 and 29.37
have tariff rates of 3% while the other have 5%.
4. Customs valuation
The Philippines has been implementing the transaction value method of customs valuation since
year 2000.
5. Prohibited and regulated drugs
(a) Prohibited drugs
Drugs and substances designed, intended or adapted for producing unlawful abortion;
Any adulterated or misbranded drug in violation of the provisions of the Food and Drugs
Act;
Marijuana, opium, poppies, coca leaves, heroin or any other narcotics or synthetic drugs which
are or may hereafter be declared habit-forming by the President of the Philippines, or any
compound, manufactured salt, derivative or preparation thereof, except when imported by the
government of the Philippines or any person duly authorized by the Dangerous Drugs Board,
for medicinal purposes only;
- 21 -
(b) Regulated drugs
Certain commodities require clearance/permits from appropriate government agencies prior to

importation into the Philippines. These commodity groups are:
-
Acetic anhydride (Dangerous Drugs Board)

Penicillin/derivatives (BFAD)
6. Regulatory guidelines
There are certain laws and administrative orders which are in force relative to the pharmaceutical
industry and there are as follows:
REPUBLIC ACTS
R.A. No. 3720
R.A. No. 6675
R.A. No. 8203
AN ACT TO ENSURE THE SFETY AND PURITY OF FOODS, DRUGS, AND

COSMETICS BEING MADE AVAILABLE TO THE PUBLIC BY CREATING
THE FOOD AND DRUG ADMINISTRATION WHICH SHALL ADMINISTER
AND ENFORCE THE LAWS PERTAINING THERETO.
AN ACT TO PROMOTE, REQUIRE AND ENSURE THE PRODUCTION OF AN
ADEQUATE SUPPLY, DISTRIBUTION, USE AND ACCEPTANCE OF DRUGS
AND MEDICINES IDENTIFIED BY THEIR GENERIC NAMES
AN ACT OF PROHIBITING COUNTERFEIT DRUGS, PROVIDING PENALTIES
FOR VIOLATIONS AND APPROPRIATING FUNDS THEREFOR
ADMINISTRATIVE ORDERS
A.O. No. 99 s. 2000
BANNING AND WITHDRAWAL OF THE FIXED DOSE COMBINATION

DRUG PRODUCT LORATADINE + PSEUDOEPHEDRINE (CLARINASE)
FROM THE MARKET
A.O. No. 98 s. 2000
VOLUNTARY WITHDRAWAL OF ASTEMIZOLE (HISMANAL) FROM THE

MARKET
A.O. No. 97 s. 2000
BANNING AWITHDRAWAL OF CISAPRIDE (PREPULSID) FROM THE

MARKET
A.O. No. 85 s. 2000
REGISTRATION, REQUIREMENTS FOR A GOVERNMENT AGENCY

IMPORTING A PHARMACEUTICAL PRODUCT WITH A REGISTERED
COUNTERPART BRAND IN THE PHILIPPINES
A.O. No. 23-C s. 2000
POLICIES AND GUIDELINES ON OVER-THE-COUNTER (OTC) DRUG

PRODUCTS
A.O. No. 41 s. 1991
GUIDELINES ON ADVERTISEMENT AND PROMOTIONS OF VETERINARY

DRUGS AND PRODUCTS
- 22 -
A.O. No. 99 s. 1990
A.O. No. 85 s. 1990
REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF

PHARMACEUTICAL PRODUCTS CONTAINING FOUR OR MORE ACTIVE
INGREDIENTS OUTSIDE THE COVERAGE OF A.O. 85 S. 1990
REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF
PHARMACEUTICAL PRODUCTS CONTAINING TWO OR MORE ACTIVE
INGREDIENTS
A.O. No. 56 s. 1989
REVISED
REGULATIONS
FOR
ESTABLISHMENTS AND OUTLETS
A.O. No. 55 s. 1988
REQUIREMENTS FOR LABELLING MATERIALS OF PHARMACEUTICAL

PRODUCTS
A.O. No. 99-A s. 1984
REGULATION PART C-11: LISTING OF LOCAL HERBAL AND/OR

TRADITIONAL DRUGS
A.O. No. 42 s. 1982
REGULATION PART C-10: DRUGS REGISTRATION OF HEALTH AND/OR

TRADITIONAL DRUGS BOTH LOCAL AND IMPORTED
E.
THE
Useful addresses
1. Department of Trade and Industry

Bureau of Export Trade Promotion
5-8th Floor, New Solid Bldg.,
357 Sen. Gil J. Puyat Avenue,
Makati City,
Contact Number/s :
Phone: (63-2) 7593381, 8953654, 8990133
Fax : (63-2) 8904707, 8904716
Board of Investments
5th Floor, Industry & Investments Bldg.
Makati City
Contact Number/s :
Phone : (63-2) 8909330, 8909332, 8976682 loc 248
Fax : (63-2) 8953512
Bureau of Import Services
3rd Floor, Oppen Bldg.
Makati City
Contact Number/s :
Phone : (63-2) 8964430
Fax : (63-2) 8957466
- 23 -
LICENSING
OF
DRUG
Center for International Trade Expositions and Missions

Golden Shell Pavilion,
Roxas Blvd. corner Sen. Gil J. Puyat Avenue,
Pasay City
Contact Number/s :
Phone : (63-2) 8312382, 8323956, 8312201 loc 236
Fax : (63-2) 8323965, 8340177
2. Department of Health
San Lazaro Compound,
Tayuman, Sta. Cruz, Manila
Philippines 1003
Phone : (632) 743.8301 to 23
Fax : (632) 743.1829
Email : info@doh.gov.ph
Bureau of Food and Drugs
Civic Drive, Filinvest Corporate City
Alabang, Muntinlupa City
Philippines 1781
Contact Number/s :
Phone: (63-2) 807.0721 / 842.5606
Philippine Institute of Traditional and Alternative Health Care (PITAHC)
Unit 2402 Atlanta Centre,
31 Annapolis Street, Greenhills
San Juan, Metro Manila
Contact Number/s :
Phone : (63-2) 727.2113 / 726.3225 / 726.6377
Fax : (63-2) 727.7621 / 727.6199
3. Industry associations
Pharmaceutical Healthcare Association of the Philippines, Inc. (PHAP)
U-502 5/F One Corporate Plaza
845 Pasay Road,
Makati City 5299
Contact Number/s :
Phone: (63-2) 815.0325 / 816.7334
Fax : (63-2) 819.2702
Mr. Leo P. Wassmer
EVP - CEO
- 24 -
Chamber of Filipino Drug Manufacturers and Distributors, Inc. (CFDMD)

404 Jovan Condo
600 Shaw Blvd., cor Samat Street
Mandaluyong City
Contact Number/s :
Phone : (63-2) 535.4835
Email : CFDMD@edsamail.com.ph
Ms. Ma. Lourdes Buensuceso
President
Chamber of Herbal Industries of the Philippines, Inc. (CHIP, Inc.)
2281 2/F DMCI Complex
Pasong Tamo Extension
Makati City
Contact Number/s :
Phone : (63-2) 888.3944
Fax : (63-2) 816.7185
Mr. Horacio Abelarde
President
- 25 -
- 26 -

ANNEX I
PRODUCT COVERAGE FOR PHARMACEUTICAL PRODUCTS
HDG.
HS
PSCC
29.36
29361000
29362100
29362200
29362300
29362400
5411100
5411200
5411301
5411302
5411303
29362500
29362600
29362700
29362800
29362900
29369000
5411304
5411305
5411400
5411500
5411600
5411700
29.37
29371000
5415200
29372100
5415301
29372200
5415302
29372900
5415309
29379100
29379200
5415100
5415901
29379900
5415909
29381000
5416101
29389000
5416109
29.38
PRODUCT DESCRIPTION
Provitamins and vitamins, natural or reproduced by
synthesis (including natural concentrates), derivatives
thereof used primarily as vitamins, and intermixtures of the
foregoing, whether or not in any solvent
provitamins, unmixed (NK)
vit a & their derivatives,unmixd (NK)
vit b1 & its derivatives,unmixed (NK)
vitamin b2 & its derivatives, unmixed (NK)
d-/dl-pantothenic acid(vitamin b3/b5) & its derivatives,
unmixed (NK)
vit b6 & its derivatives,unmixed (NK)
vit b12 & its derivatives,unmixd (NK)
vit c & its derivatives,unmixed (NK)
vit e & its derivatives,unmixed (NK)
oth vits & their derivtv;unmixed (NK)
intermixtures of provitamins & vitamins wtr/not in any
solvent (NK)
Hormones, natural or reproduces by synthesis; derivatives
thereof, used primarily as hormones, other steriods used
primarily as hormones
pituitary(anterior)/simlr hormones, & their derivtv, not as
medicment (NK)
cortisone,hydrocortisone,prednisone & prednisolone,not as
medicaments (NK)
halogenated derivtv of adrenal cortical hormones,not as
medicaments (NK)
oth adrenal cortical homrones & their derivtv, not as
medicaments (NK)
insulin & its salts, not put up as medicaments (NK)
oestrogens & progestogens, not put up as medicaments
(NK)
oth hormones & oth hormone derivtv; oth steroids as
hormone,not as medic (NK)
Glycosides, natural or reproduced by synthesis , and their
salts, ethers, esters and other derivatives
rutoside(rutin) & its derivtv, not put up as medicaments
(NK)
oth glycosided,nat'l/reproduced by synthesis&their
dervtv,not as medic (NK)
- 27 -
HDG.
HS
PSCC
29.39
29391000
5414100
29392100
29392900
5414201
5414209
29393000
29394100
29394900
5414300
5414401
5414409
29395000
5414500
29396200
29396900
5414602
5414609
29397000
29399000
5414700
5414909
29411000
5413100
29412000
5413200
29413000
29413000
5413301
5413309
29414000
5413901
29415000
5413902
29419000
29419000
29419000
5413903
5413904
5413905
29419000
5413909
29.41
PRODUCT DESCRIPTION
Vegetable alkaloids, natural or reproduced by synthesis and
their salts, ethers, esters and other derivatives
alkaloids of opium & derivtv; salts, not put up as
medicaments (NK)
quinine & its salts, not put up as medicaments (NK)
oth alkaloids of cinchona & derivtv; salts, not put up as
medicaments (NK)
caffeine & its salts,not put up as medicaments (NK)
Ephedrine and its salts (NK)
other ephedrines and their salts, not put up as medicaments
(NK)
theo-/amino- phylline & their derivtv; salts, not put up as
medicaments (NK)
ergotamine (inn) and its salts (NK)
other alkaloids of rye ergot and their derivatives; salts
thereof, not put up as medicaments (NK)
nicotine & its salts, not put up as medicaments (NK)
oth veg alkaloids; derivtv of alkaloids nes, & their salts, nes
(NK)
Antibiotics
penicillins&derivtv w/ penicillanic acid stru; salts,not as
medicmnt (NK)
streptomycins & their derivtv; salts, not put up as
medicaments (NK)
terramycin; salts, not put up as medicaments (NK)
oth tetracyclines & their derivtv; salts, not put up as
medicaments (NK)
chloramphenicol&derivtv, chloromycetin; salts, not put up
as medicaments (NK)
erythromycin&derivtv, incldg ilotycin, erythrocin,salts,not
as medicmnt (NK)
bacitracin; salts, not put up as medicaments (NK)
neomycin;salts,not as medicmnt (NK)
antibiotics for veterinary use; salts, not put up as
medicaments (NK)
oth antibiotics, & salts, nes, not put up as medicaments
(NK)
- 28 -
HDG.
HS
PSCC
30.01
30011000
5416201
30012000
5416202
30019000
30019000
5416203
5416209
30.02
30021000
30021000
30021000
30.03
5416301
5416303
5416309
30022000
30022000
30022000
30022000
30023000
5416311
5416313
5416321
5416329
5416341
30023000
30029000
30029000
5416349
5416401
5416402
30029000
5416405
30029000
5416403
PRODUCT DESCRIPTION
Glands and other organs for organo-therapeutic uses, dried,
whether or not powdered; extracts of glands or other organs
or of their secretions for organo-therapeutic uses; heparin
and its salts; other human animal substances prepared for
therapeutic or prophylactic uses, not elsewhere specified or
included
glands & oth organs, for organo-therapeutc
uses,dried,powdered/not (NK)
xtract of glands/oth organs/their secretions for organotherapeutc (NK)
heparin & its salts (NK)
oth human/animal subs preprd for therapeutic/prophylactic
uses (NK)
Human blood; animal blood preapred for therapeutic,
prophylactic or diagnostic uses; antisera and other blood
fractions and modified immunological products, whether or
ot obtained by means of biotechnological processes;
vaccines, toxins, cultures of micro-organisms (excluding
yeasts) and similar products
antisera [, bulk] (NK)
blood globulins, serum globulins & hemoglobin (NK)
other blood fractions and modified immunological products,
whether or not obtained by means of biote (NK)
Cholera, dysentery & typhoid vaccine, (bulk) NK
rabies vaccine [, bulk] (NK)
Poliomyelitis & staphylococci vaccines (bulk) NK
other vaccines for human medicine [, bulk] (NK)
veterinary vaccines against foot and mouth disease [, bulk]
(NK)
other veterinary vaccines [,bulk] (NK)
human blood (NK)
animal blood preprd for therapeutic, prophylactic/diagnostic
uses (NK)
toxins, cultures of micro-organisms (excluding yeasts) and
similar products [, bulk] (NK)
antitetanic serum [, bulk] (NK)
Medicaments (excluding goods of hdg 30.03, 30.05 or
30.06) consisting of two or more constituents which have
been mixed together for therapeutic or prophylactic uses,
not put up in measured doses or in forms or packings for
retail sale
- 29 -
HDG.
HS
PSCC
PRODUCT DESCRIPTION
30031000
5421101
30031000
5421104
30031000
5421105
30031000
5421109
30032000
5421202
30032000
5421203
30032000
5421204
30032000
30033100
5421209
5422100
30033900
5422201
30033900
5422209
30034000
5423109
30039000
5429101
30039000
5429102
30039000
5429107
30039000
5429108
30039000
5429111
30039000
5429119
medicmnt containing
penicillin, not put in
doses(/form/packgs for retail (NK)
medicmnt contg Erythromycin, not put up in
doses/form/packgs for retail, (NK)
medicmnt w/ penicillin/derivtv,penicillanic acid stru,for
veterinary (NK)
oth medicmnt w/ penicillins/derivtv, w/ penicillanic acid
stru, etc (NK)
medicmnt contg chloramphenicol,not in doses/form/packg
for retail (NK)
medicmnt
contg
terramycin,not
put
up
in
doses/forms/packings for retail (NK)
medicmnt contg oth antibiotics for vete rinary,not
doses/form for retail (NK)
medicmnt contg oth antibiotics (NK)
medicmnt contg insulin, not put up in doses/forms/packings
for retail (NK)
medicmnt w/ antidiabetic preptn, not in doses/packings for
retail (NK)
medicmnt w/ oth-hormone/prodct FO 54145, not in
doses/packg for retail (NK)
medicmnt w/ alkaloids & derivtv, nes, not in doses/packg
for retail (NK)
medicmnt contg sulfonamides & sulfonamide comp, in
doses/packg for retail (NK)
medicmnt contg enzymes, not put up in doses/forms/packg
for retail (NK)
medicmnt w/ analgesics & antipyretics, not in doses/packg
for retail (NK)
medicmnt w/ shcistosomiasis medicine, not in doses/packg
for retail (NK)
veterinary medicmnt, not in doses/form/ packg for retail,oth
thn 5429104 (NK)
oth medicmnt, nes, not put up in doses/forms/packings for
retail (NK)
30.04
Medicaments (excluding goods of hdg 30.03, 30.05 or

30.06) consisting of mixed or unmixed products for
therapeutic or prophylactic uses, put up in measured doses
(including those in the form of transdermal administration
systems) or in forms or packings for retail sale
30041000
5421301
medicmnt contg penicillin, put up in doses/forms/packings

for retail (NK)
- 30 -
HDG.
other
HS
PSCC
PRODUCT DESCRIPTION
5421302
medicmnt contg erythromycin/dihydrostrep-tomycin in

doses/oth for retail (NK)
medicmnt
contg
erythromycin,put
up
in
medicmnt w/ penicillins/derivtv, etc, for retail sale, for
veterinary (NK)
oth
medicmnt
w/
penicillins/derivtv,etc
in
doses/form/packing for retail (NK)
medicmnt contg bacitracin, put up in doses/forms/packings
for retail (NK)
medicmnt
contg
chloramphenicol,
put
up
in
doses/forms/packg for retail (NK)
medicmnt contg terramycin, put up in doses/forms/packings
for retail (NK)
medicmnt w/ oth antibiotics for veterinary use,in doses/oth
for retail (NK)
medicmnt w/ oth antibiotics,nes, in doses/forms/packg for
retail (NK)
medicmnt contg insulin, put up in doses/forms/packings for
retail (NK)
medicmnt
contg
adrenal
cortex
hormones,
in
medicmnt w/ oth-hormone/prodct of 5415, in
doses/forms/packgs for retail (NK)
medicmnt contg opium alkaloids,in doses forms/packings
for retail sale (NK)
medicmnt w/ alkaloids, of cinchona bark, in
doses/form/packing for retail (NK)
medicmnt
w/
alkaloids&alkaloids
derivtv
,in
doses/form/packg for retail (NK)
medicmnt
w/
vit/oth
prodct
of
5411,
in
specialized medicines for cancer, aids and other dreaded
diseases (NK)
closed sterile water system for inhalation, pharmaceutical
grade (usp, nf or bp) (NK)
sulfonamides & sulfonamide comp, in doses/forms/packings
for retail (NK)
Medicated
candies,cough-syrups&drops,in
veterinary medicine for eradication of parasites, for retail
sale (NK)
30041000
5421304
30041000
5421305
30041000
5421309
30042000
5421901
30042000
5421902
30042000
5421903
30042000
5421904
30042000
5421909
30043100
5422300
30043200
5422400
30043900
5422900
30044000
5423201
30044000
5423202
30044000
5423209
30045000
5429200
30049010
5429314
30049020
5429316
30049090
5429301
30049090
5429303
30049090
5429305
- 31 -
HDG.
HS
PSCC
PRODUCT DESCRIPTION
30049090
5429306
30049090
5429307
30049090
5429308
30049090
5429311
30049090
5429312
30049090
30049090
5429315
5429319
veterinary medicmnt doses/forms/packg/ for retail sale, oth

thn 5429305 (NK)
anaesthetics, put up in measured doses/ forms/packings for
retail sale (NK)
glucose, preprd as medicmnt, put up in doses/forms packing
for retail sale (NK)
trypanocidal and antiluetic preptn, in doses/forms/packings
for retail (NK)
analgesics & antipyretics, put up in doses/forms/packings
for retail (NK)
water, medicinal, distilled, packed for retail (NK)
oth medicmnt w/ oth medicinal & pharmaceutical prodct,
nes, for retail sale (NK)
Source : Bureau of Export Trade Promotion
- 32 -

ANNEX II
PRODUCT COVERAGE FOR NATURAL PRODUCTS
HDG.
HS
PSCC
12.11
121220
12111000
12112000
12119000
12119000
12119000
12119000
2924100
2924200
2924901
2924902
2924903
2924904
12119000
12122000
2924909
2929700
13011000
13011000
13012000
13019000
13019000
13019000
13019000
13019000
13019000
13019000
2922101
2922109
2922200
2922901
2922902
2922903
2922904
2922905
2922906
2922909
13.01
1302
13021100
13021200
13021300
13021400
13021900
13022000
13023100
2929401
2929402
2929403
2929404
2929409
2929500
2929601
13023200
13023910
2929602
2929603
PRODUCT DESCRIPTION
Plants and parts of plants (including seeds and fruits), of a
kind used primarily in perfumery, in pharmacy or for
insecticidal, fungicidal or similar purposes, fresh or dried,
whether or not cut, crushed or powdered.
liquorice roots (nk)
ginseng roots (nk)
eucalyptus leaves (nk)
cinchona bark (nk)
cedar powder (nk)
pyrethrum (nk)
other plants and parts of plants (including seeds and fruits) of
a kind used primarily in perfumery, (nk)
seaweeds and other algae (nk)
Lac, natural gums, resins, gum-resins and oleoresins (for
example, balsams)
shellac (nk)
oth lac (nk)
gum arabic (nk)
resin, copal(almaciga) (nk)
gum, elemi (nk)
gum, tragacanth (nk)
gum, guar (nk)
resin, natural (nk)
incense & myrrh (nk)
oth nat gum,gum-resins & balsam (nk)
Vegetable saps and extracts; pectic substances, pectinates
and pectates, agar-agar and other mucilages and thickeners,
whether or not modified, derived from vegetable products.
Vegetale saps and extracts
opium sacs & extracts
liquorice saps & extracts (nk)
extracts of hops (nk)
extracts of pyrethrum/roots of plants contg rotenone (nk)
oth vegetable saps & extracts (nk)
pectic substances, pectinates&pectates (nk)
agar-agar, whether or not modified (nk)
mucilages and thickeners, whether or not modified, derived
from vegetable products
mucilages and thickeners derived from locust beans, locust
bean seeds or guar seed, whether or not m (nk)
carrageenan (nk)
- 33 -
HDG.
HS
PSCC
13023990
2929609
1508.1
15089000
4213100
4213900
mucilages and thickeners derived from vegetable products,

n.e.s., whether or not modified (nk)
Ground-nut oil and its fractions, whether or not refined, but
not chemically modified
groundnut(peanut) oil, crude (nk)
groundnut(peanut) oil, refined & its fractions (nk)
4223100
4223900
4224100
4224900
coconut (copra), palm kernel or babassu oil and fractions

thereof, whether or not refined, but not chemically modified
coconut(copra)oil, crude (gk)
coconut(copra) oil, refined & its fractions (gk)
palm kernel/babassu oil, crude (nk)
palm kernel/babassu oil, refined and fractions thereof (nk)
15.08
15.13
15131100
15131900
15132100
15132900
15.15
15151100
15151900
15152100
15152900
15153000
4221100
4221900
4216100
4216900
4225000
15154000
15155000
4229100
4218000
15159000
4229902
15159000
4229901
15159000
4229903
15159000
4229909
1516
15161000
151620
15162010
4312100
15162090
4312209
4312201
PRODUCT DESCRIPTION
Other fixed vegetable fats and oils (including jojoba oil) and
their fractions, whether or not refined, but not chemically
modified
linseed oil, crude (nk)
linseed oil, refined & its fractions (nk)
maize(corn) oil, crude (nk)
maize(corn) oil, refined & its fractions (nk)
castor oil & its fractions (nk)
tung oil and its fractions, whether or not refined, but not
chemically modified (nk)
sesame(sesamum) oil & its fractions (nk)
jojoba oil and its fractions, whether or not refined, but not
tobacco seed oil and its fractions, whether or not refined, but
not chemically modified (nk)
oiticica oil and its fractions, [refined, solidified or hardened
by mechanical means] whether or not (nk)
other fixed vegetable fats and oils, and their fractions, [crude,
refined or fractionated, n.e.s.] w (nk)
Animal or vegetable fats and oils and their fractions, partly
or sholly hydrogenated, inter-esterified, re-esterified or
elaidinised, whether or not refined, but not further prepared.
animal
fats&oils&fractions,hydrogenated
inter-/reesterified/elaidinized (nk)
Vegetable fats and oils and their fractions
hydrogenated vegetable fats in flakes (nk)
other vegetable fats and oils and their fraction partly or
wholly hydrogenated (other than in flakes (nk)
- 34 -
HDG.
HS
PSCC
PRODUCT DESCRIPTION
15211000
15219000
15219000
4314101
4314109
4314201
Vegetable waxes (other than triglycerides), bees wax, other

insect waxws and spermaceti, whether or not refined or
coloured
carnauba wax (nk)
oth veg waxes, wtr/not colored (nk)
beeswax (nk)
15219000
15219000
18040000
4314202
4314209
724000
spermaceti, crude, pressed/refined, wtr/not colored (nk)

oth insect waxes, wtr/not refined/ colored (nk)
cocoa butter, fat/oil (nk)
1521
1804
3203
32030000
32030000
32030000
32030000
5322201
5322202
5322203
32030000
5322209
33.01
33011100
33011200
33011200
33011300
33011300
33011400
33011400
5513121
5513103
5513113
5513101
5513111
5513102
5513112
33011900
5513109
33011900
5513119
33012200
33012300
33012600
5513225
5513226
5513227
Coloring matter of vegetable or animal origin (including

dyeing extracts but excluding animal black) whether or not
chemically defined
natural indigo (nk)
annatto(achuete) (nk)
food color, of veg/animal origin (nk)
oth coloring matter of veg/animal origin & preptns based
thereon (nk)
Essential oils (terpeneless or not) including corncretes and
absolutes; resinoids; extracted oleoresins; concentrates of
essential oilsin fats, in fixed oils, in waxes or the like,
obtianed by enfleurage or maceration; terpenic by productsof the deterpenation of essential oils, aqueous
distillates and aqueous solutions of essential oils.
Essential oils of citrus fruit
bergamot oil (nk)
orange oil for mfr of medicine (nk)
orange oil oth for mfr of medicn (nk)
lemon oil for mfr of medicine (nk)
lemon oil oth for mfr of medcine (nk)
lime oil for mfr of medicine (nk)
lime oil oth for mfr of medicine (nk)
oth essetial oils of citrus fruits for manufacture of medicine
(nk)
oth essential oils of citrus fruits oth for the manufacture of
medicine (nk)
Essential oils other than those of citrus fruit
jasmin oil (nk)
lavender/lavandin oil (nk)
vetiver oil (nk)
- 35 -
- 36 -

ANNEX III
PHILIPPINES TOP IMPORTERS OF PHARMACEUTICAL PRODUCTS
(Contact information updated as of April 2004)
1. NOVARTIS HEALTHCARE PHILS.
Address
:
Asian Reinsurance Building
Salcedo cor. Gamboa Sts.
Legaspi Village, Makati City 1229
Contact
:
Telephone
:
(632) 815.9371
Facsimile
:
Email Address
:
Novartis.com
2. PFIZER, INC.
Address
Contact
Telephone
Facsimile
Email Address
:
:
:
23/F Ayala Life FGU Center,

6811 Ayala Avenue,
Makati City
Mr. Gerry Bacaro
Country Manager
(632) 888-6001
(632) 864-3708
dina.mendez@pfizer.com
3. GLAXOSMITHKLINE PHILIPPINES INC.

Address
:
2266 Chino Roces Avenue,
Makati City
Contact
:
Mr. Amado Tuzon Tadena
President and Managing Director
Telephone
:
(632) 892-0761
Facsimile
:
(632) 893-8019
Email Address
:
lito.t.tadena@gsk.com
4. VITACHEM INDUSTRIES
Address
:
44 Zamboanga Street,
Nayon Kanluran 1104 Quezon City
Contact
:
Mr. Felix Co
General Manager
Telephone
:
(632) 372-8210
Facsimile
:
(632) 372-8218
Email Address
:
vitachem@surfshop.net.ph
5. ASTRA ZENECA PHARMACEUTICALS (PHILIPPINES), INC.
Address
:
Km. 14 South Superhighway
Paraaque City, Metro Manila
Contact
:
Mr. Rodrigo Bayna
Business Development Director
Telephone
:
(632) 823-8169
Facsimile
:
(632) 824-1298
Email Address
:
rodrigo.bayna@astrazeneca.com
- 37 -
6. UNITED LABORATORIES, INC.

Address
:
No. 66 United Street
Mandaluyong City
Contact
:
Mr. Carlos C. Ejercito
President
Telephone
:
(632) 631-8501 to 50
Facsimile
:
(632) 631-6036 / 631-6017
Email Address
:
rmgamboa@unilab.com.ph
7. ROCHE (PHILIPPINES) INC.
Address
:
Roche Building, 2252 Don Chino Roces Avenue
1231 Makati City
Contact
:
Mr. Warwick Bedwell
General Manager
Telephone
:
(632) 893-4567
Facsimile
:
(632) 893-3030
Email Address
:
Business Line
:
diagnostic analytical systems
8. BASF PHILIPPINES INC.
Address
:
Road 5, Phase 1 G12 Carmelray Industrial Park I
4028 Calubang, Calamba, Laguna
Contact
:
Telephone
:
(649) 549-0001
Facsimile
:
(649) 549-1026
Email Address
:
9. BOEHRINGER INGELHEIM (PHILIPPINES) INC.
Address
:
23F Citibank Tower, Citibank Plaza,
8741 Paseo De Roxas,
Salcedo Village, Makati City
Contact
:
Mr. Stefan Kilian
President and Managing Director
Telephone
:
(632) 867-0800
Facsimile
:
(632) 848-0506
Email Address
:
kilian@man.boehringer-ingelheim.com
10. BAYER PHILS., INC.
Address
:
Contact
Telephone
Facsimile
Email Address
:
:
:
Bayer House, Canlubang Industrial Estate

Calamba, Laguna
Mr. Gregorio V. Pangan
Vice President, Business
(649) 549-7375 loc. 3760
(649) 549-2905
greg.pangan.gp@bayer-ag.dc
- 38 -
11. SANOFI-SYNTHELABO
Address
:
3/F Feliza Building VA Rufino Street,
Legaspi Village, Makati City
Contact
:
Mr. Peter Dolinsky
President
Telephone
:
(632) 840-3888
Facsimile
:
(632) 813-1676
Email Address
:
peter.dolinsky@sanofi-synthelabo.com
12. SCHERING-PLOUGH CORP.
Address
:
12/F San Miguel Properties Centre
St. Francis Street, Ortigas Center
Mandaluyong City
Contact
:
Mr. Leo Riconalla
Division Manager
Telephone
:
(632) 637-0594
Facsimile
:
(632) 638-7709
Email Address
:
www.schering-plough.com.ph
13. MERCK, SHARP & DOHME PHILS.
Address
:
26/F Philamlife Tower,
8767 Paseo de Roxas, Makati City
Contact
:
Mr. Michael Harris
Managing Director
Ms. Grace Pitco
Customer Service Officer
Telephone
:
(632) 885-0700 to 29
Facsimile
:
(632) 885-07773 to 75
Call Center
:
(632) 878-6338
Email Address
:
www.msd.com.ph
14. BRISTOL MYERS SQUIBB MEAD JOHNSON
Address
:
2309 Pasong Tamo Extension,
Makati City
Contact
:
Telephone
:
(632) 841-8181
Facsimile
:
Email Address
:
15. ZUELLIG PHARMA CORPORATION
Address
:
Zuellig Building,
Malugay Street corner Sen. Gil J. Puyat Avenue
Makati City
Contact
:
Telephone
:
(632) 819-1561
Facsimile
:
Email Address
:
- 39 -
16. SERVIER, PHILS

Address
Contact
Telephone
Facsimile
Email Address
:
:
:
2 corner Orion and Merceds Streets,

Bel Air Subdivision, Makati City
Mr. Philippe Molhant
Managing Director
(632) 897-8990
(632) 897-9027
philippe.molhant@ph.netgers.com
17. ABBOTT LABORATORIES (PHILIPPINES)

Address
:
102 E. Delos Santos Ave., cor Madison St., Mandaluyong City
Contact
:
Mr. Edwin D. Feist
President
Telephone
:
(632) 631-8471 to 87
Facsimile
:
(632) 631-8488; (02) 634-0041
Email Address
:
N/A
18. MERIAL PHILIPPINES, INC.
Address
:
Unit 2504 25th Floor Discovery Center
#25 ADB Ave., Ortigas Center, Pasig City
Contact
:
Dr. Daniel Rodriguez
General Manager
Telephone
:
(632) 689-1030 to 35
Facsimile
:
(632) 910-6840
Email Address
:
daniel.rodriguez@merial.com
19. AVENTIS PHARMA, INC.
Address
:
12/F The Orient Square,
Emerald Ave., Ortigas Center,
Pasig City 1605, Metro Manila
Contact
:
Mr. Jean-Marie Arnaud
Chairman of the Board/President & General Manager
Telephone
:
(632) 638-1369 to 74
Facsimile
:
(632) 638-6907
Email Address
:
jm.arnaud@aventis.com
20. WYETH PHILIPPINES
Address
:
2236 Chino Roces Ave.,
Makati City
Contact
:
Mr. Andrew Santos
Sales Director/Marketing
Telephone
:
(632) 843-0941 to 50/884-6600 to 05
Facsimile
:
(632) 817-3523/813-2162 (Mr. Santos)
Email Address
:
N/A
- 40 -
21. ELI LILLY PHILIPPINES, INC.

Address
:
18TH Floor, Robinsons Galleria Center,
EDSA cor. Ortigas Avenue, Quezon City
Contact
:
N/A
Telephone
:
(632) 634-5704/634-5646
Facsimile
:
(632) 634-7334
Email Address
:
N/A
22. AVENTIS PASTEUR
Address
:
Contact
Telephone
Facsimile
Email Address
:
:
:
23. MERCK, INC.

Address
Contact
Telephone
Facsimile
Email Address
:
:
:
:
5TH Floor, Gammon House,

110 Rada Street, Legaspi Village, Makati City
Mr. Paul-Alan Dollinger
President
(632) 816-1709
(632) 815-2979
paul-alan.dollinger@aventis.com
7TH Floor, Vernida IV Building,
128 Alfaro Street, Makati City
N/A
N/A
(632) 812-6241 to 50; 817-5408
(632) 810-3024;818-6262
24. ALCON LABORATORIES (PHILS.), INC.

Address
:
3/F LGI Bldg., Ortigas Ave.,
Greenhills, San Juan, Metro Manila
Contact
:
Mr. Gnoy Daguimol
Production Planning Manager
Telephone
:
(632) 721-3957 to 59
Facsimile
:
(632) 722-4167
Email Address
:
N/A
25. SOLVAY PHARMA, INC. PHILIPPINES
Address
:
2/F Port Royal Place,
118 Rada St., Legaspi Village, Makati City
Contact
:
Mr. Marcus P.M. Wondergem
President / CEO
Telephone
:
(632) 894-0688
Facsimile
:
(632) 894-1071
Email Address
:
leabola@wtouch.com.ph
- 41 -
- 42 -

ANNEX IV
PRICE LIST OF PRESYONG TAMA, GAMOT PAMPAMILYA (RIGHT PRICE FOR FAMILY MEDICINES)
- 43 -
(Prices in Philippine Pesos per Table / Bottle / Unit )

GENERIC
NAME
SUGGESTED
RETAIL
PRICE
CURRENT
MARKET
PRICE
SAVINGS
MANUFACTURER
Cotrimoxazole
Cotrimoxazole
Ciprofloxacin
Ciprofloxacin
Cefalexin
Cefalexin
Cefalexin
Co-amoxiclav
Co-amoxiclav
Nicholas Piramal (Roche)

Nicholas Piramal (Roche)
Bayer
Bayer
Glaxo
Glaxo
Glaxo
Medreich Sterilab (Glaxo)
Medreich Sterilab (Glaxo)
2.80
5.10
19.50
32.50
11.80
21.55
99.75
51.20
63.50
14.80
26.00
54.50
75.75
18.25
33.75
165.50
69.75
87.25
12.00
20.90
35.00
43.25
6.45
12.20
65.75
18.55
23.75
81%
80%
64%
57%
35%
36%
40%
27%
27%
Nifedipine
Diltiazem
Diltiazem
Atenolol
Metoprolol
Metoprolol
Bayer
Parke Davis
Parke Davis
ICI
Astra-IDL
Astra-IDL
5.75
9.65
15.25
8.70
4.70
8.20
29.75
25.40
35.70
22.00
10.20
17.70
24.00
15.75
12.20
13.30
5.50
9.50
81%
62%
36%
60%
54%
54%
PHP
ANTI BACTERIALS
- 44 -
BACTRIM ADULT 400/80mg tab

BACTRIM DS 800/160mg tab
BAYCIP (Ciprobay) 250 mg tab
BAYCIP (Ciprobay) 500 mg tab
PHEXIN (Ceporex) 250mg cap
PHEXIN (Ceporex) 500mg cap
PHEXIN (Ceporex) 250mg/5ml, 30ml susp
AUGMENTIN 375mg tab
AUGMENTIN 625mg tab
ANTI-HYPERTENSIVES
ADALAT RETARD 20 mg tab
IONOZEM (Dilzem) 30mg tab
IONOZEM (Dilzem) 60mg tab
TENORIM 50mg tab
BETALOC 50mg tab
BETALOC 100mg tab
DRUG / DOSAGE
DRUG / DOSAGE
SUGGESTED
RETAIL
PRICE
CURRENT
MARKET
PRICE
Parke Davis
Parke Davis
Novartis
Novartis
Novartis
5.40
8.65
5.85
7.80
10.40
Glibenclamide
Glibenclamide
Hoechst Marrion Roussel

Hoechst Marrion Roussel
Isosorbide Dinitrate
Isosorbide Dinitrate
Gemfibrozil
Gemfibrozil
SAVINGS
PHP
10.50
20.85
17.20
23.00
33.50
5.10
12.20
11.35
15.20
23.10
49%
59%
66%
66%
69%
3.10
5.20
8.90
9.25
5.80
4.55
65%
49%
Wyeth
Wyeth
2.60
3.50
11.254
9.75
8.65
6.25
77%
64%
Parke Davis
Parke Davis
19.15
38.35
36.50
67.75
17.35
29.40
48%
43%
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

PONSTAN 250mg tab
PONSTAN 500mg tab
VOVERAN (Voltaren) 50mg tab
Mefenamic Acid
Mefenamic Acid
Diclofenac
Diclofenac
Diclofenac
- 45 -
ORAL HYPOGLYCEMIC/ANTI-DIABETES AGENTS

DAONIL 5mg tab
EUGLUCON 5mg tab
ANTI-ANGINAL AGENTS
ISORDIL 5mg tab SL tab
ISORDIL 10mg tab SL tab
ANTI-CHOLESTEROL AGENTS
LOPID 300mg cap
LOPID 600mg cap
MANUFACTURER
GENERIC NAME
DRUG / DOSAGE
MANUFACTURER
SUGGESTED
RETAIL
PRICE
CURRENT S A V I N G S
MARKET
PHP
%
PRICE
Terbutaline Sulfate
Terbutaline Sulfate
Terbutaline Sulfate
Terbutaline Sulfate
Salbutamol
Astra-IDL
Astra-IDL
Astra-IDL
Astra-IDL
Glaxo
3.60
5.85
217.15
80.85
159.60
8.25
19.75
438.00
155.20
314.25
4.65
13.90
242.60
81.85
154.65
56%
70%
53%
50%
49%
Salbutamol
Glaxo
72.10
151.85
79.75
53%
Gremedies (Boehringer)
28.60
68.75
40.15
58%
Gremedies (Boehringer)
4.85
9.00
4.15
46%
J & J (Janssen)
4.75
9.75
5.50
54%
RPG (Searle)
RPG (Searle)
RPG (Searle)
RPG (Searle)
RPG (Searle)
3.25
8.10
11.30
16.80
17.80
7.00
20.00
20.50
40.00
138.00
3.75
11.90
9.20
23.20
120.20
54%
60%
45%
58%
87%
BRONCHODILATORS
- 46 -
BRICANYL 2.5mg tab

BRICANYL 5mg tab
BRICANYL 250mcg x 200doses inh
BRICANYL 1.5mg/5ml, 100ml syr
VENTORLIN
(Ventolin)
100mcgx200doses inh
VENTORLIN (Ventolin) 2mg/5ml,
100ml syr
ANTI-MOTILITY AGENTS/ANTI-DIARREHALS
BUSCOPAN 20mg/ml inj
Hyoscine-Nbutylbromide
BUSCOPAN 10mg tab
Hyoscine-Nbutylbromide
IMODIUM 2mg cap
Loperamide
ANTI-PSYCHOTICS
SERENACE 1.5mg tab
SERENACE 5mg tab
SERENACE 10mg tab
SERENACE 20mg tab
SERENACE 5mg/ml inj
Haloperidol
Haloperidol
Haloperidol
Haloperidol
Haloperidol
GEN??ERIC
NAME
DRUG / DOSAGE
GENERIC NAME
MANUFACTURER
SUGGESTED
RETAIL
PRICE
CURRENT S A V I N G S
MARKET
PHP
%
PRICE
- 47 -
TEGRITAL (Tegretol) 200mg tab

TEGRITAL CR (Tegretol) 400mg
tab
TEGRITAL (Tegretol) 100mg/5ml,
100ml syr
DILANTIN 100MG CAP
Carbamazepine
Carbamazepine
Novartis
Novartis
6.05
11.15
15.00
38.00
13.95
26.85
70%
71%
Carbamazepine
Novartis
119.20
275.00
155.80
57%
Phenytoin
Parke Davis
4.80
21.40
16.60
78%
Cefuroxime
Cefuroxime
Cefuroxime
Clindamycin
Clindamycin
Cotrimoxazole
Glaxo
Glaxo
Glaxo
Pharmacia
Pharmacia
Burroughs Wellcome
33.30
65.75
126.00
32.55
47.00
67.60
33.50
78.50
140.25
34.75
52.00
88.40
0.20
12.75
14.25
4.10
7.75
20.40
1%
16%
10%
11%
14%
23%
Serdia (Servier)
9.45
11.50
2.05
ANTI-BACTERIALS
CEFTUM (Zinacef) 125mg tab
DALACIN-C 150mg cap
DALACIN-C 300mg cap
SEPTRAN
(Septrin)
200/40mg/5ml,50ml susp
ORAL HYPOGLYCEMIC/ANTI-DIABETES AGENTS

DIAMICRON 80mg tab
Gliclazide
18
%
ANTI-EPILEPTICS
- 48 -

ANNEX V
PHILIPPINE IMPORTS OF PHARMACEUTICAL PRODUCTS
CIF Value in US Dollars
1999 2003
- 49 -
2003
PSCC
2002
2001
2000
1999
DESCRIPTION
TOTAL
Value
%Share
388,820,537
100.00
Quantity
Value
Quantity
361,632,590
Value
Quantity
336,369,863
Value
Quantity
325,404,975
Value
362,128,667
Ave. Growth Rate
2.06
- 50 -
5429319
oth medicmnt w/ oth medicinal &

pharmaceutical prodct, nes, for
retail sale (nk)
7,447,271
205,359,508
52.82
7,777,533
180,495,577
6,536,186
169,226,103
4,971,445
147,644,228
5,099,741
167,669,175
5.78
5413909
oth antibiotics, & salts, nes, not put

up as medicaments (NK)
673,371
18,959,291
4.88
1,153,473
20,055,543
517,739
16,899,597
315,103
20,075,270
239,073
28,271,721
-7.90
5421909
medicmnt w/ oth antibiotics,nes, in

588,172
17,934,748
4.61
511,347
22,326,691
770,953
18,643,547
734,120
26,468,933
531,238
38,751,158
-15.29
5429314
specialized medicines for cancer,

aids and other dreaded diseases (nk)
1,864,736
14,079,831
3.62
1,431,446
15,006,763
1,155,274
12,283,700
2,118,082
12,477,922
1,207,173
10,841,257
7.38
5421309
oth medicmnt w/ penicillins/derivtv,etc

in doses/form/ packing for retail (NK)
822,519
14,061,646
3.62
339,872
7,308,250
196,727
3,706,821
238,789
4,369,032
308,817
6,992,694
34.22
5416349
214,714
13,156,917
3.38
227,497
14,775,399
248,812
14,346,794
239,221
13,670,029
172,399
15,533,176
-3.75
5422900
medicmnt w/ oth-hormone/prodct of
5415, in doses/forms/packgs for retail
(NK)
443,307
13,006,709
3.35
328,017
10,449,714
137,092
9,385,707
129,566
6,145,134
53,101
6,619,382
20.35
5411400
1,136,479
9,330,823
2.40
984,075
5,060,451
1,020,493
5,807,647
1,052,808
6,492,880
866,119
6,216,528
16.36
Quantity
5416329
other vaccines for human medicine

[, bulk] (NK)
111,899
9,058,532
2.33
135,417
11,646,507
111,595
11,700,778
83,880
9,738,928
62,172
7,753,814
5.77
10
5429200
medicmnt w/ vit/oth prodct of 5411,

in doses/forms/packings for retail
(nk)
554,601
7,911,805
2.03
642,084
6,325,350
677,705
10,907,697
486,722
8,881,632
467,194
11,840,371
-4.78
11
5416309
other blood fractions and modified

immunological products, whether
or not obtained by means of biote
(NK)
43,176
7,844,504
2.02
49,378
10,991,587
35,923
5,836,997
131,004
4,879,898
63,408
3,742,986
27.42
12
5429119
oth medicmnt, nes, not put up in

doses/forms/packings for retail (nk)
1,177,107
6,237,711
1.60
1,046,909
6,339,203
2,087,824
6,390,282
582,549
5,752,770
626,625
4,278,616
10.78
13
5421301
medicmnt contg penicillin, put up in

doses/forms/ packings for retail
(NK)
106,967
6,184,229
1.59
59,858
5,254,943
67,723
4,261,282
52,747
2,975,706
56,753
1,869,768
35.84
14
5411700
intermixtures of provitamins &

vitamins wtr/not in any solvent
(NK)
365,275
4,734,936
1.22
443,584
4,851,938
443,986
4,336,536
243,980
3,131,115
211,713
2,877,956
14.20
15
5411600
oth vits & their derivtv;unmixed

(NK)
753,117
4,430,287
1.14
409,531
5,998,340
318,204
4,558,902
260,600
2,677,709
245,083
2,593,094
19.74
16
5422300
medicmnt contg insulin, put up in

doses/forms/ packings for retail
(NK)
15,396
3,101,356
0.80
63,460
2,017,544
7,993
1,477,100
10,189
2,385,928
6,826
1,428,170
29.82
17
5411500
435,610
2,913,127
0.75
424,341
2,790,452
261,931
2,512,347
157,517
1,916,417
127,416
2,734,156
4.17
18
5413100
penicillins&derivtv w/ penicillanic
acid stru; salts,not as medicmnt
(NK)
100,009
2,812,505
0.72
103,622
2,360,374
131,283
2,837,266
647,175
4,213,226
100,401
3,641,380
-3.65
19
5411200
vit a & their derivatives,unmixd

(NK)
108,563
2,811,109
0.72
131,335
2,923,154
160,248
3,172,084
58,980
1,881,563
284,828
2,533,326
7.80
20
5413902
erythromycin&derivtv,
incldg
ilotycin, erythrocin,salts,not as
medicmnt (NK)
25,740
2,687,986
0.69
30,196
1,947,960
23,892
3,084,316
25,610
4,128,819
99,068
3,927,738
-4.76
- 51 -
5416405
toxins, cultures of micro-organisms

(excluding yeasts) and similar
products [, bulk] (NK)
115,090
2,413,495
0.62
58,087
1,658,687
51,684
1,510,988
36,090
810,302
15,225
726,813
38.31
22
5422400
medicmnt contg adrenal cortex

hormones, in doses/forms/packg for
retail (NK)
22,575
2,162,445
0.56
18,366
1,909,629
16,718
1,914,620
35,461
2,907,141
39,619
4,099,361
-12.56
23
5414300
caffeine & its salts,not put up as

medicaments (NK)
281,470
1,957,388
0.50
240,314
1,757,687
246,776
1,850,621
164,335
1,308,946
268,035
2,108,965
2.45
24
5423209
medicmnt w/ alkaloids&alkaloids
derivtv ,in doses/form/packg for
retail (nk)
96,429
1,747,771
0.45
106,867
1,321,232
45,535
997,326
18,217
1,892,106
62,707
2,390,701
-0.85
25
5413309
oth tetracyclines & their derivtv;

salts, not put up as medicaments
(NK)
490,820
1,444,269
0.37
448,578
982,664
659,644
1,706,081
173,698
1,024,117
147,017
970,439
19.17
26
5421209
47,047
1,369,802
0.35
36,790
2,253,766
29,919
1,059,370
64,174
1,663,118
21,111
2,306,272
2.34
27
5411303
d-/dl-pantothenic
acid(vitamin
b3/b5) & its derivatives, unmixed
(NK)
129,055
1,329,698
0.34
199,955
1,876,007
109,719
1,441,445
1,599,277
1,473,829
86,186
1,607,067
-2.37
28
5422209
Medicmnt w/ oth-hormone/prodct
FO 54145, not in doses/packg for
retail
55,885
1,196,525
0.31
31,806
684,375
7,768
182,445
25,370
355,676
40,683
353,906
75.44
29
5411301
vit b1 & its derivatives,unmixed

(NK)
43,552
794,432
0.20
52,499
744,041
66,095
881,951
58,217
840,165
68,105
1,135,470
-7.48
30
5411304
vit b6 & its derivatives,unmixed

(NK)
87,263
688,046
0.18
69,269
822,475
49,330
713,876
35,676
615,494
41,325
886,286
-3.93
31
5411302
vitamin b2 &
unmixed (NK)
derivatives,
43,698
619,131
0.16
50,787
846,377
40,291
844,653
43,929
899,703
77,548
1,280,870
-15.63
32
5411305
vit b12 & its derivatives,unmixd

(NK)
14,186
598,021
0.15
56,527
1,133,708
61,859
1,100,236
26,918
836,512
47,619
813,738
-2.47
its
- 52 -
21
5429303
medicated
candies,coughsyrups&drops,in
132,421
519,660
0.13
42,824
232,492
143,605
538,023
115,409
776,488
106,405
376,776
35.53
34
5415302
halogenated derivtv of adrenal

cortical
hormones,not
as
medicaments (NK)
2,100
430,672
0.11
3,783
1,150,896
3,445
1,801,829
1,542
1,546,696
849
2,364,589
-29.20
35
5416202
xtract of glands/oth organs/their

secretions for organo-therapeutc
(NK)
18,330
420,612
0.11
15,235
571,560
20,334
481,200
15,346
774,045
17,453
1,514,034
-23.59
36
5429316
closed sterile water system for

inhalation, pharmaceutical grade
(usp, nf or bp) (nk)
30,167
403,306
0.10
19,870
188,160
10,128
112,869
356,330
9,363,407
20.57
37
5414909
oth veg alkaloids; derivtv of

alkaloids nes, & their salts, nes
(NK)
42,299
358,525
0.09
23,040
336,754
28,224
500,878
7,275
455,341
5,539
326,394
5.80
38
5416402
animal blood preprd for therapeutic,

prophylactic/diagnostic uses (NK)
68,937
358,041
0.09
25,394
115,032
7,518
219,284
48
791
1,169
80,450
6921.77
39
5429306
veterinary
medicmnt
doses/forms/packg/ for retail sale,
oth thn 5429305 (nk)
26,357
353,190
0.09
13,855
211,429
3,672
218,479
14,391
239,158
15,640
183,033
21.46
40
5413901
chloramphenicol&derivtv,
chloromycetin; salts, not put up as
medicaments (NK)
20,567
349,833
0.09
19,505
335,266
85,815
638,849
127,901
839,583
25,921
889,125
-18.17
41
5413301
terramycin; salts, not put up as

medicaments (NK)
49,384
302,100
0.08
15,200
20,187
20,415
25,471
2,265
32,772
921
9,465
399.93
42
5416401
human blood (NK)
1,734
252,068
0.06
532
120,689
41,673
126,508
1,532
76,254
898
153,379
29.97
43
5413905
antibiotics for veterinary use; salts,

not put up as medicaments (NK)
17,340
247,213
0.06
9,847
95,583
2,524
26,688
76,678
39,487
96.10
44
5421109
oth medicmnt w/ penicillins/derivtv,

w/ penicillanic acid stru, etc (NK)
8,448
221,402
0.06
35,740
132,782
6,367
36,677
63,079
330,097
-30.54
- 53 -
33
5423109
medicmnt w/ alkaloids & derivtv,

nes, not in doses/packg for retail
(nk)
12377
184318
0.05
4310
76280
2858
74753
701
103444
335
7723.69
46
5415301
cortisone,hydrocortisone,prednison
e
&
prednisolone,not
as
medicaments (NK)
1,179
141,635
0.04
1,462
165,059
6,844
442,622
446
329,227
425
333,416
-10.93
47
5415901
oestrogens & progestogens, not put

185
126,572
0.03
20,954
307,252
5,128
160,299
1,415
275,328
6,788
312,734
-5.22
48
5413200
streptomycins & their derivtv; salts,

4,536
113,235
0.03
29,038
372,411
34,314
416,931
47,002
1,330,047
61,911
3,355,662
-52.32
49
5421204
medicmnt contg oth antibiotics for

vete rinary,not doses/form for retail
(NK)
7,704
99,921
0.03
7,949
68,113
5,011
22,047
63.91
50
5421904
medicmnt w/ oth antibiotics for

veterinary use,in doses/oth for
retail (NK)
13,173
92,129
0.02
4,990
89,950
12,389
381,962
8,509
375,051
35,827
190,216
6.25
51
5416403
antitetanic serum [, bulk] (NK)
838
89,349
0.02
129
1,214
731
234,401
3,295
30,664
438
69,274
1942.27
52
5429315
water, medicinal, distilled, packed

for retail (nk)
23,902
75,607
0.02
40
39,423
272
36,323
8,585
87,189
-37.45
53
5416109
oth glycosided,nat'l/ reproduced by

synthesis&their dervtv,not as
medic (NK)
9,229
73,029
0.02
42,509
247,132
11,074
166,408
6,677
123,537
1,080
105,151
7.56
54
5429305
veterinary medicine for eradication

of parasites, for retail sale (nk)
2,000
67,600
0.02
1,171
10,481
-25.00
55
5416209
oth human/animal subs preprd for

therapeutic/prophylactic uses (NK)
5,117
59,197
0.02
1,138
78,754
20,764
220,214
4,108
256,008
3,763
179,262
-15.06
56
5422100
medicmnt contg insulin, not put up

(NK)
563
52,705
0.01
2,444
150,496
206
71,184
814
79,176
10
1,214
1614.57
57
5416101
rutoside(rutin) & its derivtv, not put

226
49,497
0.01
694
124,112
751
119,999
150
31,253
48,732
211,829
35.51
- 54 -
45
5421304
medicmnt contg erythromycin,put

up in doses/forms/packings for
retail (NK)
293
43,090
0.01
1,363
18,499
-25.00
59
5415309
oth adrenal cortical homrones &

their derivtv, not as medicaments
(NK)
40,391
0.01
620
52,377
9,149
92,235
2,104
19,627
5,504
130,156
54.73
60
5414500
theo-/amino- phylline & their

derivtv; salts, not put up as
medicaments (NK)
2,753
39,615
0.01
152,925
200,072
3,182
216,542
2,196
265,601
4,363
259,289
-25.96
61
5416341
veterinary vaccines against foot

and mouth disease [, bulk] (NK)
1,541
36,382
0.01
3,389
143,160
14,182
575,271
16,132
917,676
8,474
404,510
-15.04
62
5429301
sulfonamides & sulfonamide comp,

(nk)
762
33,528
0.01
17,967
287,728
35
2,601
2715.55
63
5423201
medicmnt contg opium alkaloids,in

doses forms/packings for retail sale
(nk)
12377
28,858
0.01
481
25,113
1,216
101,705
663
131,176
-20.72
64
5415909
oth hormones & oth hormone

derivtv; oth steroids as hormone,not
as medic (NK)
2,764
27,870
0.01
7,155
148,650
19,326
152,765
834
102,991
279
102,577
-8.80
65
5411100
3,640
27,849
0.01
6,965
196,344
66,155
539,547
45,449
286,438
-15.27
66
5429111
veterinary
medicmnt,
not
in
doses/form/ packg for retail,oth thn
5429104 (nk)
4,060
27,433
0.01
1,288
13,738
266
12,122
46,542
165,766
3,055
59,866
49.31
67
5421901
medicmnt contg bacitracin, put up

(NK)
2,027
20,905
0.01
806
73,206
7,361
172,256
3,280
84,359
-6.19
68
5414100
alkaloids of opium & derivtv; salts,

180
17,839
0.00
1,205
56,500
90,664
62,211
10,685
39,318
2,679
18,427
23.50
69
5414409
other ephedrines and their salts,

2,000
16,068
0.00
1,068
19,434
527
19,846
-25.52
70
5414602
ergotamine (inn) and its salts (NK)
15,908
0.00
158
23,106
-25.00
- 55 -
58
5414209
oth alkaloids of cinchona & derivtv;

salts, not put up as medicaments
(NK)
501
14,351
0.00
200
7,736
400
51,748
461
57,557
1,782
70,805
-7.09
72
5414201
quinine & its salts, not put up as

medicaments (NK)
105
7,575
0.00
100
6,500
197
11,111
477
9,087
31
3,827
33.69
73
5429312
analgesics & antipyretics, put up in

3,072
7,206
0.00
7,397
79,594
610
29,143
18.28
74
5416201
glands & oth organs, for organotherapeutc

uses,dried,powdered/not (NK)
140
7,182
0.00
609
16,948
1,227
17,300
-25.51
75
5421305
medicmnt w/ penicillins/derivtv, etc,

for retail sale, for veterinary (NK)
496
6,535
0.00
728
45,252
2,115
11,013
9,187
83,598
7,372
167,891
22.08
76
5421202
medicmnt
contg
chloramphenicol,not
in
doses/form/packg for retail (NK)
95
5,255
0.00
158
10,664
-12.68
77
5421203
medicmnt contg terramycin,not put

up in doses/forms/
packings for
retail (NK)
300
4,926
0.00
0.00
78
5423202
Medicmnt w/ alkaloids, of cinchona

bark, in doses/form/packing for
retail
20,080
4,800
0.00
0.00
79
5421902
medicmnt contg chloramphenicol,

put up in doses/forms/packg for
retail (NK)
1,634
3,690
0.00
132
3,116
14,252
220,346
218
25,380
8,993
92,265
153.88
80
5413904
neomycin;salts,not
(NK)
medicmnt
200
2,148
0.00
699
5,811
1,187
13,977
3,735
61,914
104
3,167
414.02
81
5429307
anaesthetics, put up in measured

doses/ forms/packings for retail
sale (nk)
760
1,039
0.00
595
40,450
1,251
29,567
-15.80
82
5416203
heparin & its salts (nk)
60
95
0.00
198
699
1,603
5,761
1,067
7,023
1,304
94,590
-71.21
83
5413903
bacitracin; salts, not put up as

medicaments (NK)
0.00
3,600
16,137
4,349
274,601
1,815
3708.85
as
- 56 -
71
5414401
Ephedrine and its salts (NK)
0.00
270
41,573
-25.00
85
5414609
other alkaloids of rye ergot and

their derivatives; salts thereof, not
put up as medicaments (NK)
0.00
3,745
90
912
86
3,630
33.94
86
5414700
nicotine & its salts, not put up as

medicaments (NK)
0.00
1,000
5,983
-25.00
87
5415100
insulin & its salts, not put up as

medicaments (NK)
0.00
4,982
12,783
477
83,158
13
3,016
494
92,235
593.97
88
5415200
pituitary(anterior)/simlr hormones, &

their derivtv, not as medicment
(NK)
0.00
150
3,556
82,000
73,445
16,329
82,610
-51.56
89
5416301
antisera [, bulk] (NK)
0.00
133
18,448
1,152
64,451
132
20,255
1,175
183,225
-10.53
90
5416303
blood globulins, serum globulins &

hemoglobin (NK)
0.00
1,330
238,065
1,107
195,309
44,130
226,698
1,486
218,700
-22.08
91
5416311
Cholera, dysentery
vaccine, (bulk) NK
0.00
1,888
187,704
58
2,362
204
17,318
1915.12
92
5416313
0.00
327
204,501
284
47,140
1,252
544,546
35.62
93
5416321
Poliomyelitis
&
staphylococci
vaccines (bulk) (NK)
0.00
314
21,473
1,389
134,207
589
80,956
-29.56
94
5421101
Medicmnt contg Penicillin, not put

up in does/form/packgs for retail
0.00
850
25,237
-25.00
95
5421104
Medicmnt contg Erythromycin, not

put up in doses/form/packgs for
retail
0.00
240
48,275
-25.00
96
5421302
Medicmnt
w/
Streptomycin/dihydrostrep-tomycin
in doses/oth for retail
0.00
3,055
54,230
38,220
10,449
79.75
97
5421903
medicmnt contg terramycin, put up

(NK)
0.00
838
20,925
630
3,558
4,471
67,376
1,734
44,297
86.37
98
5422201
Medicmnt w/ antidiabetic preptn,

not in doses/forms/packings for
retail
0.00
27
4,526
-25.00
&
typhoid
- 57 -
84
5429101
medicmnt
contg
sulfonamides&sulfonamide
comp,in dose/packg for retail (nk)
0.00
106,600
117,898
57
7,770
329.34
100
5429102
medicmnt contg enzymes, not put

retail (nk)
0.00
4,384
1,987
-25.00
101
5429107
medicmnt
w/
analgesics
&
antipyretics, not in doses/packg for
retail (nk)
0.00
11,459
116,626
-25.00
102
5429108
medicmnt
w/
shcistosomiasis
medicine, not in doses/packg for
retail (nk)
0.00
120
5,622
-25.00
103
5429308
glucose, preprd as medicmnt, put

retail (nk)
0.00
1,721
9,072
-25.00
104
5429311
trypanocidal and antiluetic preptn,

(nk)
0.00
1,171
5,896
10
1,182
3,319
117,076
49.71
- 58 Source : Bureau of Export Trade Promotion
99
ANNEX VI
PHILIPPINE SUPPLYING COUNTRIES OF PHARMACEUTICAL PRODUCTS
1999 - 2003
2002
2001
2000
1999
%
Share
2003
Ave.
Growth
Rate
Country
2003
TOTAL
Top 10
388,820,537 361,632,590 336,369,863 325,404,975 362,128,667 100.00

283,900,448 258,497,919 237,962,881 232,231,062 257,159,505 73.02
Others
104,920,089 103,134,671 98,406,982
93,173,913
104,969,162 26.98
0.00
0.23
Switzerland
44,919,865
36,655,116
32,666,616
37,537,735
40,667,023
11.55
3.52
Germany
38,577,452
36,655,283
34,623,403
26,340,513
33,588,575
9.92
5.24
France
36,112,162
33,118,211
28,333,168
26,005,034
22,368,550
9.29
12.78
GB and North Ireland
32,519,186
33,725,135
29,323,847
26,536,101
29,436,399
8.36
3.02
Australia
32,247,545
23,305,190
26,679,636
30,874,415
34,016,152
8.29
0.73
USA (Ex. Hawaii, Alaska)
23,284,938
25,053,239
30,522,385
33,046,442
43,055,215
5.99
-13.97
Singapore
21,505,074
24,657,195
21,631,243
20,719,465
20,162,419
5.53
2.09
Italy
20,013,290
16,422,214
13,123,014
12,464,364
18,734,045
5.15
4.71
India
19,795,306
18,627,069
10,421,101
8,400,888
5,730,609
5.09
38.91
10 Netherlands
14,925,630
10,279,267
10,638,468
10,306,105
9,400,518
3.84
13.67
11 Sweden
12,397,106
14,811,885
11,112,321
5,780,613
7,960,382
3.19
20.46
12 Belgium
12,390,857
10,636,649
10,535,785
10,820,338
11,413,369
3.19
2.41
13 China, P. Rep. Of
10,310,774
7,655,341
7,493,841
4,731,815
5,331,431
2.65
20.99
14 Japan
9,022,673
9,845,556
7,898,338
9,568,553
12,088,166
2.32
-5.50
15 Hong Kong S.A.R.
7,593,989
4,882,496
8,089,366
15,745,597
20,235,692
1.95
-13.73
16 Austria
6,147,000
6,206,322
5,003,956
4,328,002
3,912,524
1.58
12.33
17 Korea, Rep. (South)
5,311,127
5,515,349
7,500,957
4,198,495
4,744,753
1.37
9.24
18 Spain
4,957,742
5,297,215
5,602,299
5,721,569
6,222,439
1.28
-5.50
19 Ireland
4,598,981
6,888,160
6,463,131
5,551,850
5,754,557
1.18
-3.44
20 Denmark
4,545,060
3,369,310
2,482,964
2,594,637
2,905,219
1.17
13.90
21 Puerto Rico
4,375,202
3,113,744
1,361,810
823,992
752,991
1.13
60.96
22 Thailand
4,243,333
8,759,978
8,233,552
5,797,018
7,166,167
1.09
-5.56
23 Indonesia (Incl. West 4,002,520
3,996,083
5,183,959
4,712,596
5,275,752
1.03
-5.86
2.06
2.81
Irian)
24 Taiwan
3,311,888
2,416,672
2,902,412
2,500,934
1,984,499
0.85
15.60
25 Malaysia
2,673,923
3,069,648
2,149,226
1,960,887
1,736,472
0.69
13.12
26 Mexico
1,380,267
1,953,129
917,133
908,215
847,019
0.35
22.96
- 59 -
27 Pakistan, Is.mic Rep.
1,380,234
1,186,623
960,957
1,664,410
1,117,741
0.35
11.61
28 Panama
1,308,524
123,416
398,260
658,937
456,103
0.34
224.04
29 Canada
1,012,482
650,468
1,020,481
600,303
2,039,955
0.26
4.70
30 Brazil
983,979
632,590
721,448
886,992
478,099
0.25
27.52
31 Finland
910,128
325,586
548,252
670,561
255,691
0.23
70.73
32 Bulgaria
448,923
123,059
11,934
0.12
41.20
33 Croatia
307,690
229,065
216,170
146,423
101,732
0.08
32.96
34 Hungary
256,070
216,811
237,491
493,802
493,980
0.07
-10.64
35 South Africa Rep. Of
189,785
236,015
219,573
271,097
205,777
0.05
0.16
36 Argentina
160,256
256,248
178,793
67,898
204,437
0.04
25.60
37 Turkey
113,197
95,992
1,758
0.03
1315.07
46,767
117,865
57,469
204,584
0.03
23.02
97,839
58,100
211,324
155,761
217,697
0.03
0.78
40 Honduras
67,509
0.02
41 Afghanistan
66,533
0.02
42 Cyprus
46,156
11,170
15,233
17,302
0.01
43 Poland
41,685
11,462
0.01
44 Uruguay
30,150
60,341
53,037
0.01
-50.00
45 Norway
24,945
4,149
92,255
1,746
0.01
1247.07
46 Bangladesh
21,729
34,078
22,595
45,849
21,765
0.01
18.63
47 Paraguay
21,343
0.01
48 Vietnam
14,079
273
101
11,343
6,918
0.00
1298.07
49 Macau
10,000
60,001
30,046
0.00
-0.08
50 French Pacific Isl.
9,808
48,685
0.00
51 Canal Zone
8,323
0.00
52 Luxembourg
7,347
245,788
13,168
25,959
12,642
0.00
431.40
53 Greece
5,115
15,750
646,072
0.00
-49.39
54 Dominica
4,276
0.00
55 Colombia
4,100
65,183
101,074
0.00
56 Alaska
1,581
0.00
57 Uzbekistan
1,342
472,200
0.00
58 Bahrain
21,095
0.00
59 Barbados
6,893
0.00
38 New
(Excludes
Samoa)
39 Israel
Zealand 102,519
Western
60 Belize
(British 0
Honduras)
61 Burkina Faso
0
62 Canary Islands
0
44,023
1,296
58,104
0.00
18,554
0
0
0
0
161,164
0
0
0.00
0.00
63 Chile
910
298,926
0.00
64 Christmas Island
33,103
0.00
65 Czech Republic
90,095
2,251
0.00
- 60 -
68.65
-8.88
774.77
-49.92
-50.00
66 Egypt
22,032
0.00
Guinea, 0
17,021
0.00
17,572
0.00
69 French West Indies
2,495
92,538
0.00
70 Gambia
12,576
0.00
71 Guam
2,161
0.00
72 Hawaii
636
0.00
73 Kuwait
2,000
0.00
74 Malta & Gozo
12,416
14,500
0.00
75 Mozambique
1,806
0.00
76 Myanmar (Burma)
1,182
0.00
77 Peru
3,860
0.00
78 Portugal
16,597
17,009
51,345
0.00
-42.32
79 Romania
80,636
13,501
5,631
0.00
134.26
80 Russian Federation 0
(U.S.S.R.)
17,637
0.00
81 Sao
Tome
And 0
Principe, Dem. Rep.
Of
82 Saudi Arabia
0
63,683
0.00
33,901
0.00
83 Senegal
47,979
0.00
Republic 0
2,688
0.00
85 Slovenia
85,619
0.00
86 Somalia
284
0.00
87 South And Southeast 0

Asia, N.E.S.
28,999
0.00
88 Sri Lanka (Ceylon)
4,018
0.00
89 Suriname
7,050
0.00
90 Swaziland
7,749
0.00
91 Tanzania,
Rep. Of
United 0
66,364
0.00
92 Trust Territory Of 0
The Pacific Islands
434
7,776
0.00
93 Tunisia
318
0.00
94 Ukraine
S.S.R)
(Ukrainian 0
74,467
0.00
175
60,907
4,942
0.00
67 Equatorial
Rep. Of
68 Fiji
84 Slovak
(Slovakia)
95 United Arab Emirates
- 61 -
-50.00
-28.59
233.18
- 62 -
ANNEX VII
PHILIPPINE IMPORTS OF NATURAL PRODUCTS
1999 - 2003
- 63 -
2003
PSCC
2002
2001
2000
Ave.
Growth
Rate
1999
DESCRIPTION
Quantity
% Share
39,425,960
100.00
Quantity
Value
Quantity
34,266,281
Value
Quantity
34,600,838
Value
Quantity
32,245,687
Value
34,974,263
3.40
4312201
hydrogenated vegetable fats in flakes

(nk)
13,732,449
6,618,030
16.79
13,943,690
6,325,136
16,908,730
5,999,830
9,703,068
4,076,352
10,696,330
6,134,172
5.92
2929603
carrageenan (nk)
489,836
4,277,463
10.85
600,869
3,099,797
907,943
3,446,758
348,842
2,728,647
285,418
1,601,352
31.16
2929700
seaweeds and other algae (nk)
5,455,330
3,694,690
9.37
2,167,030
1,756,320
2,796,671
2,088,961
1,397,214
1,378,362
1,294,907
1,034,528
44.81
2922909
oth nat gum,gum-resins & balsam (nk)
4,111,410
3,273,459
8.30
4,096,365
3,658,625
3,650,895
3,587,690
2,119,110
2,363,576
2,499,069
2,609,834
8.45
4312209
other vegetable fats and oils and their

fraction partly or wholly hydrogenated
(other than in flakes (nk)
5,233,722
2,422,712
6.14
5,018,751
2,716,256
2,367,667
1,580,597
2,013,728
1,190,483
2,681,836
1,801,849
14.97
5513119
oth essential oils of citrus fruits oth for

the manufacture of medicine (nk)
124,655
2,085,778
5.29
129,002
2,365,182
135,876
1,866,060
53,221
750,745
67,692
431,970
59.33
4221900
2,220,281
1,808,019
4.59
2,319,537
1,432,073
2,644,019
1,563,480
2,017,221
1,269,721
2,492,716
1,945,306
1.57
2929402
liquorice saps & extracts (nk)
179,581
1,792,498
4.55
859
117,964
2,075
23,438
266,596
2,296,739
216,514
1,459,618
445.30
2929403
110,498
1,658,894
4.21
123,648
2,313,616
85,940
1,791,157
107,267
1,600,991
116,912
1,222,960
10.92
10
2929602
mucilages and thickeners derived from

locust beans, locust bean seeds or guar
seed, whether or not m (nk)
447,318
1,366,507
3.47
301,594
970,945
341,006
1,244,940
372,434
1,807,001
373,614
1,495,386
2.12
- 64 -
TOTAL
Value
animal fats&oils&fractions,hydrogenated
inter-/re-esterified/elaidinized (nk)
1,357,497
1,251,606
3.17
1,404,798
933,149
2,246,042
1,390,848
1,958,105
1,597,397
1,407,639
1,371,879
1.18
12
4216900
maize(corn) oil, refined & its fractions

(nk)
991,041
998,470
2.53
1,367,675
954,951
1,465,627
1,097,183
1,127,510
1,012,223
1,097,706
1,152,586
-3.05
13
2929500
pectic substances, pectinates&pectates

(nk)
117,924
961,639
2.44
36,178
341,440
25,334
321,270
29,387
173,759
29,283
348,039
55.69
14
2922200
gum arabic (nk)
420,314
928,810
2.36
448,091
1,007,366
562,997
1,166,476
385,469
872,662
294,497
646,907
11.78
15
2929609
mucilages and thickeners derived from

vegetable products, n.e.s., whether or
not modified (nk)
118,114
722,463
1.83
273,661
1,214,545
254,289
1,073,713
270,428
1,200,499
511,060
2,447,687
-22.23
16
4229909
other fixed vegetable fats and oils, and

their fractions, [crude, refined or
fractionated, n.e.s.] w (nk)
395,163
674,856
1.71
1,072,083
402,220
2,678,621
1,264,568
2,168,458
1,486,423
1,809,052
1,102,927
4.86
17
4218000
sesame(sesamum) oil & its fractions

(nk)
540,852
606,082
1.54
672,172
465,486
614,017
695,029
659,491
583,097
556,273
762,631
-1.79
18
2929409
oth vegetable saps & extracts (nk)
112,956
562,806
1.43
67,860
554,431
106,671
656,958
90,580
581,089
87,831
551,587
1.08
19
5513111
26,735
436,135
1.11
10,653
181,738
57,212
574,491
68,512
1,100,189
50,761
719,332
19.20
20
5513113
30,273
392,687
1.00
28,875
279,766
27,146
187,352
45,734
241,620
13,548
276,177
13.68
21
4314109
854,035
332,263
0.84
1,676,599
448,809
129,728
83,701
45,276
73,329
54,607
123,038
96.00
22
5513109
oth essetial oils of citrus fruits for

manufacture of medicine (nk)
19,644
322,215
0.82
61,417
621,694
102,826
524,956
1,907
95,525
40,478
296,891
88.00
23
4225000
158,086
298,469
0.76
169,670
149,989
56,834
99,729
125,236
172,494
60,858
83,385
53.52
4312100
- 65 -
11
2924909
other plants and parts of plants

(including seeds and fruits) of a kind
used primarily in perfumery, (nk)
80,592
291,876
0.74
94,952
166,372
106,093
96,811
66,330
146,895
130,371
249,309
18.03
25
5513112
46,100
229,278
0.58
410
26,276
2,103
44,479
1,180
67,942
2,299
59,894
177.64
26
5322209
oth coloring matter of veg/animal origin

& preptns based thereon (nk)
65,096
215,894
0.55
113,887
449,055
223,529
759,530
84,797
462,044
72,079
484,368
-8.26
27
2922904
gum, guar (nk)
120,605
149,043
0.38
179,721
206,969
116,875
104,765
266,152
394,342
471,289
969,508
-15.80
28
5513103
31,411
112,279
0.28
19,786
107,227
6,223
90,182
10,092
96,102
31,587
155,232
-5.16
- 66 -
29
5513101
lemon oil for mfr of medicine (nk)
4,894
103,684
0.26
3,569
86,444
4,243
83,183
5,771
62,151
14,519
233,821
-3.93
30
4314101
carnauba wax (nk)
21,828
103,345
0.26
425,990
161,368
74,640
97,262
35,731
118,603
32,106
136,855
-0.35
31
4314209
oth insect waxes,

colored (nk)
29,013
76,251
0.19
108,000
99,581
260,309
148,482
41,599
53,156
3,304
15,330
92.43
wtr/not
refined/
32
0724000
51,929
76,023
0.19
289,423
259,496
24,697
46,282
16,921
21,329
5,900
3,608
249.53
33
2922109
oth lac (nk)
4,429
74,765
0.19
664
15,653
3,332
29,847
940
8,448
145.85
34
2922101
shellac (nk)
29,762
74,342
0.19
21,323
55,921
7,638
43,577
5,951
73,166
13,448
256,463
-12.66
35
4224900
palm kernel/babassu oil, refined and

fractions thereof (nk)
258,929
53,320
0.14
184,685
15,311
1,037,618
368,176
791,388
408,201
1,158,738
749,895
24.26
36
4229100
tung oil and its fractions, whether or not

refined, but not chemically modified (nk)
38,517
49,180
0.12
91,270
67,284
92,000
64,972
99,791
90,296
92,054
91,280
-13.12
37
4314201
beeswax (nk)
11,397
43,575
0.11
9,455
33,313
8,677
45,528
15,975
100,102
17,363
58,024
5.49
38
2922903
3,000
41,143
0.10
1,000
9,250
61
509
640
7,895
6,740
74,890
469.77
39
5322202
20,185
38,382
0.10
17,515
23,518
80
3,920
6,789
35,165
81,681
46,050
112.67
40
2929601
agar-agar, whether or not modified (nk)
5,817
38,278
0.10
8,717
45,441
9,272
105,343
32,105
377,727
31,338
76,790
61.79
41
5322201
natural indigo (nk)
2,000
22,962
0.06
700
9,379
-25.00
42
4221100
linseed oil, crude (nk)
22,800
21,504
0.05
767
533
65,260
38,540
18,369
15,541
-12.66
24
43
5322203
food color, of veg/animal origin (nk)
1,429
18,594
0.05
1,999
22,024
44
2,019
220
10,514
857
27,755
208.09
5513102
lime oil for mfr of medicine (nk)
360
17,261
0.04
320
11,637
1,089
19,050
1,283
5,532
2,880
31,979
42.77
45
4216100
maize(corn) oil, crude (nk)
21,942
14,530
0.04
10,003
5,866
787
822
128.41
46
4229903
oiticica oil and its fractions, [refined,

solidified or hardened by mechanical
means] whether or not (nk)
2,010
13,448
0.03
0.00
47
5513121
bergamot oil (nk)
245
10,519
0.03
949
7,922
2,243
11,521
1,198
635
-24.62
48
2924200
ginseng roots (nk)
5,733
9,728
0.02
91
2,169
906
2,783
6,323
43,185
-53.91
49
2922901
18,000
8,867
0.02
544
806
1,196
7,085
761
3,249
202.88
50
2924901
5,847
8,696
0.02
72
925
800
481
-1.92
51
4229901
tobacco seed oil and its fractions,

whether or not refined, but not
14,232
7,658
0.02
98,641
19,157
393,468
22,316
-18.55
52
4223900
coconut(copra) oil, refined & its fractions

(gk)
42,303
6,868
0.02
930,697
12,789
19,498
8,107
147,999
83,694
17,829
24,125
42.02
53
5513226
lavender/lavandin oil (nk)
275
3,778
0.01
292
4,595
638
11,358
191
2,668
361
5,595
49.02
54
4213900
groundnut(peanut) oil, refined & its

fractions (nk)
2,942
2,347
0.01
8,437
7,388
5,209
8,649
16,118
13,594
34,210
32,886
-44.46
55
2924100
liquorice roots (nk)
1,000
1,500
0.00
1,309
3,081
56
4229902
jojoba oil and its fractions, whether or

not refined, but not chemically modified
(nk)
16
491
0.00
16
385
116
371
800
578
57
2922902
gum, elemi (nk)
0.00
1,200
1,296
27,360
96,307
-50.00
58
2922905
resin, natural (nk)
0.00
31,400
20,530
51,557
12,482
54,895
82,537
-30.10
59
2922906
0.00
500
8,680
52,500
17,325
4,011
1,180
184
3,133
289.00
60
2929404
extracts of pyrethrum/roots of plants

contg rotenone (nk)
0.00
26,006
19,460
25,946
29,323
-33.41
61
4213100
groundnut(peanut) oil, crude (nk)
0.00
3,400
9,400
955
473
446.83
62
4223100
0.00
264,355
110,502
-25.00
-27.07
- 67 -
44
4224100
palm kernel/babassu oil, crude (nk)
0.00
24,065
9,095
933,699
596,661
1,994,920
1,464,968
-64.82
64
4314202
spermaceti, crude,
wtr/not colored (nk)
0.00
207
214
-25.00
65
5513225
jasmin oil (nk)
0.00
65
360
-25.00
pressed/refined,
- 68 -
63
ANNEX VIII
PHILIPPINE SUPPLYING COUNTRIES OF NATURAL PRODUCTS
1999 - 2003
2003
2002
2001
2000
1999
%
Share
2003
Ave.
Growth
Rate
TOTAL
Top 10
Others
39,425,960
33,137,706
6,288,254
34,266,281
27,759,209
6,507,072
34,600,838
27,161,166
7,439,672
32,245,687
24,193,500
8,052,187
34,974,263
27,765,365
7,208,898
100.00
84.05
15.95
3.40
5.24
-2.95
U.S.A. (Excl. Hawaii &

Alaska)
Malaysia
Indonesia
(Includes
West Irian)
Denmark
Singapore
Germany
Belgium
France
Hong Kong S.A.R.
India
China, People'S Rep. Of
Norway
Great
Britain
And
Northern Ireland
Australia
Japan
Thailand
Chile
Netherlands
Italy
Morocco
Brazil
Vietnam
Taiwan
Mexico
Canada
South Africa Rep. Of
Argentina
Pakistan, Islamic Rep.
Spain
Switzerland
Hungary
Peru
Austria
Nepal
Malta & Gozo
8,295,870
6,919,045
6,961,258
8,303,810
7,093,993
21.04
5.04
6,911,169
3,914,184
5,387,966
2,245,434
5,277,706
3,136,944
4,002,421
1,195,477
6,326,855
2,230,578
17.53
9.93
6.37
40.47
3,682,772
3,483,449
1,943,100
1,471,010
1,234,242
1,124,143
1,077,767
735,423
630,928
591,088
2,415,554
5,365,512
2,205,335
339,256
804,848
1,134,359
941,900
595,459
402,626
1,140,108
2,624,377
4,290,504
1,532,128
73,479
1,359,958
852,177
1,052,635
427,246
459,516
1,324,100
2,171,870
3,751,145
1,563,466
30,836
1,180,864
852,127
1,141,484
381,911
227,894
1,618,489
1,999,865
3,859,474
1,999,658
27,391
1,072,913
947,374
2,207,264
172,572
358,084
2,374,400
9.34
8.84
4.93
3.73
3.13
2.85
2.73
1.87
1.60
1.50
18.48
0.39
2.06
211.54
9.44
5.54
-13.04
49.01
27.40
-28.02
584,280
578,039
430,596
417,010
319,818
253,944
155,614
148,139
142,574
142,084
139,710
126,021
121,955
114,075
106,359
84,303
79,908
75,566
64,055
62,400
51,521
50,425
767,969
334,226
647,677
631,536
136,086
147,339
0
71,447
112,737
435,616
161,823
275,462
97,629
2,114
122,937
232,288
63,513
0
0
0
0
0
941,308
353,019
556,376
961,300
154,680
184,794
222,220
30,266
0
569,237
129,583
87,563
0
15,788
116,811
406,090
107,274
348
0
61,920
0
1,806
924,946
438,620
522,220
1,387,339
266,680
198,720
76,470
150,584
0
390,552
101,683
277,500
0
0
94,839
203,930
214,468
0
0
62,785
0
0
371,317
477,089
640,060
487,448
51,633
205,000
60,000
50,274
657,044
321,066
161,033
28,647
0
38,061
485
275,698
211,895
0
0
0
0
0
1.48
1.47
1.09
1.06
0.81
0.64
0.39
0.38
0.36
0.36
0.35
0.32
0.31
0.29
0.27
0.21
0.20
0.19
0.16
0.16
0.13
0.13
27.13
10.01
-7.24
21.41
124.37
10.50
29.51
90.76
-18.38
-5.87
0.45
240.14
6.23
1302.39
4867.34
-8.35
-15.94
-25.00
0.00
-25.34
0.00
-25.00
Country
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
- 69 -
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Korea, Rep. Of (South)

Israel
Benin
New Zealand (Excludes
Western Samoa)
St. Helena
Guatemala
Sweden
Turkey
Trust Territory Of The
Pacific Islands
Bahrain
Bulgaria
Ceuta And Melilla
Christmas Island
Finland
Iceland
Ireland
Kenya
Mozambique
Myanmar (Burma)
Portugal
Saudi Arabia
Sudan
Tokelau
United Arab Emirates
Venezuela
34,251
20,398
12,400
6,607
32,055
10,199
0
14,733
277,699
9,822
0
13,190
452,631
8,598
0
0
118,758
21,059
0
0
0.09
0.05
0.03
0.02
40.22
14.73
0.00
-10.86
4,366
3,148
771
327
151
0
0
4,101
221
0
0
0
4,965
415
0
0
0
5,407
496
0
0
0
4,814
0
0
0.01
0.01
0.00
0.00
0.00
0.00
0.00
-23.61
-3.78
0.00
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,620
1,543
0
0
0
0
23,378
0
0
0
4,630
0
0
0
0
0
0
0
0
0
0
0
0
650
18,225
3,036
425
0
0
0
0
0
0
0
0
2,035
6,334
15,000
0
8,700
12,225
0
0
0
1,131
0
8,845
15,378
0
0
8,795
0
64,657
7,500
0
0
0
0
0
14,974
1,734
578
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-25.00
-25.00
-25.00
-25.00
-25.00
-25.00
-47.55
0.00
-25.00
-48.13
-12.73
-25.00
222.35
-25.00
-33.69
-25.00
- 70 -
ANNEX IX
PHILIPPINE EXPORTS OF PHARMACEUTICAL PRODUCTS
FOB Value in US Dollars
1999 - 2003
- 71 -
2003
HS
PSCC
2002
2001
2000
1999
Description
Quantity
%Share
17,467,789
100.00
Quantity
Value
Quantity
16,739,713
Value
Quantity
16,483,186
Value
Quantity
16,231,188
Value
% Ave.
Growth
Rate
19,431,615
-2.25
- 72 -
3004909
0
5429319
oth medicmnt w/ oth medicinal &

pharmaceutical prodct, nes, for
retail sale (NK)
13,041,985
12,304,140
70.44
9,845,385
10,909,655
7,190,322
10,295,723
5,893,923
9,221,126
6,134,040
12,048,937
1.73
3004500
0
5429200
medicmnt w/ vit/oth prodct of 5411,

(NK)
418,693
2,513,667
14.39
420,596
3,194,454
457,146
2,860,914
676,575
3,684,877
597,264
3,633,742
-7.65
3004909
0
5429312
analgesics & antipyretics, put up in

103,088
777,859
4.45
134,491
1,015,466
110,521
832,218
163,528
1,304,987
195,279
1,609,764
-14.14
3004909
0
5429303
medicated
candies,coughsyrups&drops,in
174,418
725,724
4.15
173,742
687,259
373,510
1,399,268
238,139
990,472
162,293
705,869
9.08
3004200
0
5421909
medicmnt w/ oth antibiotics,nes, in

48,761
533,523
3.05
27,107
312,259
44,724
693,812
48,188
611,054
82,725
636,394
6.36
3004909
0
5429306
veterinary
medicmnt
doses/forms/packg/ for retail sale,
oth thn 5429305 (NK)
68,377
118,602
0.68
52,991
280,307
5,999
145,652
2,467
37,634
5,509
116,698
63.51
2936270
0
5411400
14,579
111,214
0.64
50
3,450
266
11,239
475
3,563
817.43
TOTAL
Value
30049090
5429305
veterinary medicine for eradication of

parasites, for retail sale (NK)
6,986
94,400
0.54
218
6,320
572
6,444
1,300
14,041
334.41
11
30039000
5429119
oth medicmnt, nes, not put up in

143,925
92,671
0.53
256,922
131,465
8,025
9,585
285
1,475
335,214
200,060
423.16
12
30022000
5416313
119
60,000
0.34
0.00
13
30041000
5421309
oth medicmnt w/ penicillins/derivtv,etc

in doses/form/packing for retail (NK)
1,040
31,579
0.18
139
620
1248.35
14
30041000
5421305
medicmnt w/ penicillins/derivtv, etc, for

retail sale, for veterinary (NK)
287
25,448
0.15
1,000
900
177
4,115
656.89
15
30049010
5429314
specialized medicines for cancer, aids

and other dreaded diseases (NK)
9,500
16,115
0.09
71
2,829
104
11,631
539
14,884
485
9,400
107.61
16
30023000
5416349
152
14,364
0.08
34
5,239
24
2,600
7,314
55,617
-5.29
17
30043200
5422400
medicmnt
contg
adrenal
cortex
hormones, in doses/forms/packg for
retail (NK)
685
11,400
0.07
0.00
18
30022000
5416329
other vaccines for human medicine [,

bulk] (NK)
44
11,177
0.06
264
23,953
-25.00
20
29393000
5414300
caffeine & its salts,not put up as

medicaments (NK)
500
5,295
0.03
2,500
25,947
481
4,940
4,500
25,719
12,100
67,618
50.73
21
30023000
5416341
veterinary vaccines against foot and

mouth disease [, bulk] (NK)
58
4,617
0.03
472
6,609
324
18,060
-32.54
22
30029000
5416405
toxins, cultures of micro-organisms

(excluding yeasts) and similar products
[, bulk] (NK)
720
4,576
0.03
76
605
76
561
139.09
- 73 -
10
30043900
5422900
medicmnt w/ oth-hormone/prodct of
5415, in doses/forms/packgs for retail
(NK)
537
4,398
0.03
118
1,045
790
207
5,121
67.14
24
29361000
5411100
3,500
4,332
0.02
5,693
20,584
-19.74
26
29362900
5411600
oth vits & their derivtv;unmixed (NK)
75
969
0.01
492
8,568
3,388
123,880
167
5,213
10
1,136
613.37
27
30031000
5421105
medicmnt w/ penicillin/derivtv,penicillanic acid stru,for veterinary (NK)
262
710
0.00
1,442
7,025
-25.00
28
30029000
5416402
animal blood preprd for therapeutic,

prophylactic/diagnostic uses (NK)
192
709
0.00
0.00
29
30019000
5416209
oth human/animal subs preprd for

therapeutic/prophylactic uses (NK)
300
0.00
0.00
30
30042000
5421904
medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (NK)
0.00
623
50,256
138
4,155
70
975
333.92
31
30041000
5421304
medicmnt contg erythromycin,put up

in doses/forms/packings for retail (NK)
0.00
2,838
30,759
786
11,199
988
10,948
6,025
68,733
-1.78
32
29369000
5411700
intermixtures
of
provitamins
&
vitamins wtr/not in any solvent (NK)
0.00
9,867
24,552
350
3,766
36,750
164,688
1,420
39,447
167.93
33
30032000
5421209
0.00
1,604
10,953
-25.00
34
30042000
5421903
medicmnt contg terramycin, put up in

0.00
454
9,396
110
1,417
25,599
24
11,294
2092.23
- 74 -
23
30049090
5429301
sulfonamides & sulfonamide comp, in

0.00
39
216
-25.00
36
30022000
5416311
cholera, dysentery
vaccine [, bulk] (NK)
0.00
32,645
-25.00
37
29362800
5411500
0.00
870
25,027
1,244
30,531
25
5,481
84.75
38
29362600
5411305
vit b12 & its derivatives,unmixd (NK)
0.00
61
5,069
297
2,172
-50.00
39
29419000
5413909
oth antibiotics, & salts, nes, not put up

as medicaments (NK)
0.00
236
3,195
239
6,750
736
26,352
-56.77
40
30032000
5421203
medicmnt contg terramycin,not put up

in doses/forms/packings for retail (NK)
0.00
109
1,924
-25.00
41
30049090
5429315
water, medicinal, distilled, packed for

retail (NK)
0.00
5,770
28,682
-25.00
42
30021000
5416309
other blood fractions and modified

immunological products, whether or
not obtained by means of biote (NK)
0.00
252
4,195
-25.00
43
29362100
5411200
vit a & their derivatives,unmixd (NK)
0.00
261
400
-25.00
45
30042000
5421902
medicmnt contg chloramphenicol, put

up in doses/forms/packg for retail
(NK)
0.00
5,500
174,809
-25.00
46
30039000
5429108
medicmnt
w/
shcistosomiasis
medicine, not in doses/packg for retail
(NK)
0.00
32
-25.00
and
typhoid
- 75 -
35
- 76 -
ANNEX X
PHILIPPINE EXPORT MARKETS OF PHARMACEUTICAL PRODUCTS
1999 - 2003
% Share
(2003)
Ave.
Growth
Rate
100.00
-2.25
80.60
-4.35
19.40
16.86
3,864,462
14.76
-4.68
2,827,455
2,360,480
12.29
1.91
1,811,272
1,886,775
1,650,786
10.16
3.61
1,349,810
1,112,361
702,561
278,333
8.44
60.34
1,460,504
1,491,846
1,429,642
1,692,097
1,218,679
8.36
6.40
Hong Kong S.A.R.
1,305,704
1,306,177
1,492,252
2,072,369
2,220,229
7.47
-11.79
Singapore
1,270,672
1,504,865
1,341,441
1,361,786
1,432,078
7.27
-2.45
Cambodia
Kampuchea)
903,425
439,030
322,371
314,443
587,255
5.17
24.51
Sri Lanka (Ceylon)
732,020
639,172
605,814
732,710
1,239,208
4.19
-9.54
10
Taiwan
433,531
874,865
572,015
732,276
2,215,927
2.48
-21.59
11
Indonesia (Includes West Irian)
391,480
353,434
128,769
136,361
71,834
2.24
67.37
12
390,112
102,285
138,384
191,891
142,557
2.23
65.51
13
Japan
378,921
109,747
73,393
102,797
221,274
2.17
53.16
14
Sudan
359,991
157,978
33,683
2.06
67.25
15
India
251,697
176,466
10,674
120,352
66,360
1.44
396.52
16
239,796
378
1.37
17
195,014
163,270
37,315
2,000
213,985
1.12
505.92
18
Germany
178,568
2,100
25,882
649,175
1.02
-71.97
19
131,844
36,036
3,761
23,775
5,391
0.75
345.21
20
Dominican Republic
96,987
0.56
21
U.S.A. (Excl. Hawaii & Alaska)
83,959
157,585
184,530
347,636
350,170
0.48
-27.24
22
Uganda
70,682
14,157
19,556
9,784
0.40
99.79
23
Netherlands
58,366
191,445
63,824
33,634
34,998
0.33
54.08
24
Switzerland
57,433
5,462
4,620
2,469
0.33
1.34
25
Guam
47,763
7,403
3,140
5,042
2,781
0.27
181.13
26
New
Zealand
Western Samoa)
45,394
97,336
17,967
58,160
24,231
0.26
114.83
Country
2003
2002
2001
2000
1999
TOTAL
17,467,789
16,739,713
16,483,186
16,231,188
19,431,615
Top 10
14,079,833
15,021,300
14,731,000
14,226,454
17,067,437
Others
3,387,956
1,718,413
1,752,186
2,004,734
2,364,178
Vietnam
2,577,554
2,243,450
2,052,117
1,903,982
Australia
2,146,801
2,872,482
3,991,715
Malaysia
1,774,829
2,299,603
Thailand
1,474,793
Myanmar (Burma)
(Democratic
(Excludes
- 77 -
27
Bahrain
35,039
20,444
9,363
35,270
12,688
0.20
73.57
28
Laos
33,379
22,277
20,334
14,474
12,194
0.19
29.64
29
Trinidad And Tobago
31,740
14,522
27,157
51,294
60,907
0.18
2.30
30
Austria
29,760
29
136
0.17
-44.67
31
Italy
28,500
419
57,635
66,104
0.16
1625.66
32
Kenya
28,461
30,854
13,306
49,022
14,627
0.16
71.60
33
Trust Territory Of The Pacific

Islands
26,658
23,515
13,556
8,340
1,886
0.15
122.89
34
Jamaica
22,201
4,217
10,648
14,898
11,820
0.13
90.90
35
Marshall Islands Rep. Of
20,417
64
209
0.12
-42.34
36
Papua New Guinea
16,530
2,738
3,854
12,197
0.09
-49.34
37
14,895
6,823
10,647
24,014
11,048
0.09
36.02
38
Micronesia Federated States Of
14,525
388
2,979
7,480
35
0.08
6191.96
39
Spain
13,767
20,929
129,687
60,038
1,219
0.08
1205.78
40
Chile
12,059
26,634
0.07
41
Saudi Arabia
11,641
45,135
360,504
136
0.07
66200.57
42
Egypt
9,819
7,527
1,186
0.06
-50.00
43
Colombia
9,207
1,187
0.05
44
Ethiopia
8,678
0.05
45
Belgium
6,990
137,001
4,876
152,585
0.04
628.22
46
Hawaii
5,859
1,643
3,090
1,643
8,850
0.03
54.10
47
Gibraltar
5,818
0.03
48
Mexico
5,222
132
37,166
0.03
-49.91
49
Canada
5,141
3,637
3,599
10,104
14,615
0.03
-13.21
50
Brazil
4,332
0.02
51
Qatar
2,123
1,030
2,205
7,155
0.01
-11.79
52
Great Britain
Ireland
1,828
8,486
178,451
6,138
5,101
0.01
663.49
53
Oman
1,621
7,200
2,397
0.01
30.72
54
Norway
1,536
2,019
0.01
55
Palau, Rep. Of
1,112
1,739
1,106
17,258
855
0.01
56
Vanuatu (New Hebrides)
530
412
0.00
57
France
168
17,970
456
19,103
0.00
910.79
58
Lebanon
166
191
3,013
0.00
-26.69
59
Brunei Darussalam
105
2,117
4,207
17,547
1,971
0.00
142.38
60
Kuwait
50
0.00
61
Ireland
42
254
5,401
0.00
-44.69
62
Cyprus
30
259
457
1,744
289
0.00
74.48
63
Algeria
8,829
0.00
64
American Samoa
207
291
0.00
-32.22
65
Aruba
192
613
0.00
-42.17
And
Northern
- 78 -
461.52
66
Bahamas
11,858
0.00
67
Bangladesh
66,084
1,500
0.00
1051.40
68
Barbados
349
729
0.00
-50.00
69
Canary Islands
64,881
0.00
70
Christmas Island
3,600
0.00
71
Cuba
70,786
0.00
72
Ecuador
226
0.00
73
El Salvador
4,645
0.00
74
Fiji
1,960
0.00
75
French West Indies
10,222
0.00
76
Honduras
23,778
0.00
77
Macau
496
0.00
78
Malawi
18,674
3,309
0.00
79
Malta & Gozo
700
0.00
80
Mozambique
13,000
0.00
81
Netherlands Antilles
3,087
0.00
82
Nigeria
42,004
13,459
26,531
0.00
15.70
83
Puerto Rico
204
2,653
0.00
-48.08
84
Solomon Islands (British)
1,680
0.00
85
Swaziland
375
0.00
86
Sweden
10,080
143,668
35,762
0.00
87
Tuvalu
13,377
0.00
88
Virgin Islands (British)
23,012
0.00
89
Virgin Islands (U.S.)
980
0.00
90
Zambia
8,388
16,019
0.00
- 79 -
91.08
25.43
-36.91
- 80 -
ANNEX XI
PHILIPPINE EXPORTS OF NATURAL PRODUCTS
1999 - 2003
- 81 -
2003
HS
PSCC
2002
2001
2000
1999
Product Description
Total
Value
% Share
598,228,117
100.00
Quantity
Value
Quantity
433,740,837
Value
Quantity
497,061,503
Value
Quantity
557,499,280
Value
Ave. Growth
Rate (%)
438,585,896
10.36
15131100
4223100
960,323,997
399,435,958
66.77
766,811,048
279,672,033
1,191,860,716
340,853,510
832,952,113
350,912,292
318,118,755
220,088,784
20.36
15131900
4223900
coconut(copra) oil, refined &

its fractions (gk)
223,781,454
105,424,316
17.62
177,850,087
72,953,171
226,113,791
76,695,525
227,997,970
113,183,312
159,884,951
122,194,180
0.00
- 82 -
13023910
2929603
carrageenan (nk)
10,068,951
46,953,481
7.85
8,053,702
38,383,091
8,539,935
38,239,377
7,658,265
38,353,940
8,176,372
41,543,047
3.68
12122000
2929700
seaweeds and other algae

(nk)
31,364,419
33,385,854
5.58
31,063,629
33,859,858
31,720,996
32,950,471
48,313,520
46,409,802
32,552,261
44,107,266
(5.61)
18040000
0724000
3,072,392
10,285,163
1.72
2,838,874
6,899,586
3,318,716
6,456,152
2,678,363
6,358,861
2,811,392
8,974,355
33012900
5513209
oth essential oils, nes, for the

manuf of medicine (nk)
197,201
684,821
0.11
29,426
218,410
25
1,126
33012900
5513219
other essential oils, n.e.s.,

other than for the manufacture
of medicine (nk)
123,053
501,737
0.08
29,796
81,915
6,171
26,258
245
7,150
2,135
51,675
226.39
12119000
2924909
other plants and parts of

plants (including seeds and
fruits) of a kind used primarily
in perfumery, (nk)
83,509
351,561
0.06
116,168
203,312
118,080
183,184
70,525
75,138
25,479
29,289
96.06
32030000
5322202
66,707
309,614
0.05
78,589
462,769
41,907
332,539
28,660
347,778
31,418
273,245
7.24
10
15153000
4225000
334,210
288,365
0.05
142,400
105,480
94,840
60,460
351,405
250,534
423,200
403,983
33.50
11
13019000
2922902
gum, elemi (nk)
180,500
264,168
0.04
135,850
240,830
296,168
528,342
376,842
695,597
244,610
464,335
(4.74)
12
13019000
2922901
199,159
174,809
0.03
209,080
149,893
203,500
160,659
319,368
241,508
336,365
246,769
(6.42)
7.08
4,877.63
Quantity
2929409
oth vegetable saps &

extracts (nk)
20,383
77,620
0.01
80,250
238,292
23,886
342,485
7,245
25,822
14
13019000
2922909
oth nat gum,gum-resins

& balsam (nk)
29,308
53,685
0.01
34,689
94,239
134,742
137,894
23,101
39,199
7,329
4,199
15
33019090
5513503
aqueous distillates and

aqueous solutions of
essential oils (including
such products suitable
for me (nk)
1,573
13,728
0.00
9,892
33,312
16
15154000
4229100
tung oil and its fractions,

whether or not refined,
but
not
chemically
modified (nk)
9,500
12,762
0.00
17
15159000
4229909
other fixed vegetable

fats and oils, and their
fractions, [crude, refined
or fractionated, n.e.s.] w
(nk)
16,000
4,440
0.00
18
32030000
5322209
oth coloring matter of

veg/animal origin &
preptns based thereon
(nk)
100,000
4,015
0.00
106
273
19
15155000
4218000
sesame(sesamum) oil &

its fractions (nk)
450
1,362
0.00
20
33011900
5513119
oth essential oils of

citrus fruits oth for the
manufacture
of
medicine (nk)
10
298
0.00
135
727
3,154
5,227
47
21
12119000
2924901
51
153
0.00
22
33012500
5513221
oil of eucalyptus (nk)
17
75
0.00
808
9,864
23
33012900
5513223
citronella oil (nk)
15
49
0.00
15
236
119
1,224
36
294
24
33012300
5513226
lavender/lavandin
(nk)
25
13021300
2929403
oil
15
49
0.00
177
2,193
34
0.00
26
13011000
2922109
oth lac (nk)
0.00
285
360
27
13012000
2922200
gum arabic (nk)
0.00
100
393
28
13019000
2922903
0.00
250
5,015
29
13019000
2922904
gum, guar (nk)
0.00
3,750
12,750
252.65
2,719.04
39.09
13021900
- 83 -
13
13019000
2922905
resin, natural (nk)
0.00
1,022
4,713
31
13019000
2922906
0.00
200
500
32
13021400
2929404
extracts of pyrethrum/roots of plants

contg rotenone (nk)
0.00
9,016
541,120
33
13023990
2929609
mucilages and thickeners derived

from vegetable products, n.e.s.,
whether or not modified (nk)
0.00
7,575
44,518
7,600
2,800
34
15152900
4216900
maize(corn) oil, refined & its fractions

(nk)
0.00
55,860
38,264
35
15151900
4221900
0.00
3,900
3,315
36
15159000
4229902
jojoba oil and its fractions, whether or

not refined, but not chemically
modified (nk)
0.00
301
38
15162090
4312209
other vegetable fats and oils and their

fraction partly or wholly hydrogenated
(other than in flakes (nk)
0.00
9,000
4,048
39
15211000
4314101
carnauba wax (nk)
0.00
164
1,227
50
279
2,327
62
40
15219000
4314109
0.00
543
2,716
41
15219000
4314201
beeswax (nk)
0.00
35
117
42
33011200
5513103
0.00
30
1,242
60
2,392
43
33011300
5513111
0.00
22,529
122,303
182
910
618
11,106
16,665
151,678
3,263.85
44
33011400
5513112
0.00
25
693
2,096
34,332
30
150
5,647.50
45
46
33011200
33011100
5513113
5513121

bergamot oil (nk)
0
0
0
0
0.00
0.00
0
0
0
0
0
0
0
0
0
0
0
0
8,212
50
26,827
1,741
47
33012400
5513202
peppermint(mentha piperita) oil for the

manufacture of medicine (nk)
0.00
149
96
3,079
1,452.34
(37.02)
(48.79)
- 84 -
30

ANNEX XII
PHILIPPINE EXPORT MARKETS OF NATURAL PRODUCTS
1999 - 2003
Country
2003
2002
2001
2000
1999
% Share
(2003)
Ave.
Growth
Rate
TOTAL
598,228,117
433,740,837
497,061,503
557,499,280
438,585,896
100.00
10.36
Top 10
549,449,737
384,393,977
441,074,199
494,438,935
365,754,862
91.85
13.62
Others
48,778,380
49,346,860
55,987,304
63,060,345
72,831,034
8.15
-9.41
0.00
1
Netherlands
196,563,218
116,913,944
174,804,631
147,321,120
101,508,511
32.86
24.70
U.S.A. (Excl. Hawaii & Alaska)
183,174,580
150,362,480
136,952,327
215,161,324
181,079,399
30.62
3.52
Malaysia
44,755,757
28,419,536
41,661,442
32,051,476
3,216,583
7.48
238.03
32,042,638
16,069,184
18,115,097
17,022,275
7,341,130
5.36
56.60
Japan
27,505,438
20,094,269
12,085,845
21,925,563
25,089,245
4.60
11.41
Italy
15,671,798
14,735,589
8,781,245
11,577,508
10,349,573
2.62
15.47
Denmark
15,304,252
15,570,242
15,108,739
14,016,118
12,506,126
2.56
5.30
Indonesia (Includes West Irian)
14,121,484
2,826,370
10,148,015
16,730,896
405,714
2.36
1077.99
France
13,258,685
13,044,528
11,626,732
12,588,121
19,466,458
2.22
-7.28
10
7,051,887
6,357,835
11,790,126
6,044,534
4,792,123
1.18
21.51
11
Germany
6,551,418
1,344,575
2,163,809
2,491,264
8,376,794
1.10
66.50
12
Spain
5,533,515
4,091,002
5,434,778
4,855,976
3,086,999
0.92
19.94
13
Taiwan
5,058,392
2,287,664
7,522,936
5,025,665
4,388,626
0.85
28.93
14
Great Britain
Ireland
3,767,742
4,811,479
6,401,920
17,065,749
14,388,085
0.63
-22.60
15
Thailand
3,667,531
2,049,883
1,406,619
1,911,080
2,006,073
0.61
23.38
16
Canada
3,112,211
4,943,589
5,313,322
4,100,614
3,998,516
0.52
-2.97
17
Australia
2,886,642
2,665,768
4,634,001
5,386,420
6,887,209
0.48
-17.49
18
Singapore
2,381,865
14,014,957
5,507,912
4,347,283
14,872,161
0.40
6.84
19
Belgium
2,042,183
1,450,759
2,432,973
2,009,918
3,466,001
0.34
-5.14
20
Mexico
1,978,957
1,895,247
1,613,900
2,701,029
1,113,025
0.33
31.07
21
New
Zealand
Western Samoa)
1,799,584
1,634,849
1,647,864
1,750,954
1,865,211
0.30
-0.68
22
Russian Federation (U.S.S.R.)
1,639,899
1,094,050
288,878
0.27
82.15
23
Chile
1,549,053
1,518,286
1,712,709
1,857,866
1,616,884
0.26
-0.56
24
Sri Lanka (Ceylon)
1,131,372
1,093
750
0.19
25
Brazil
1,089,049
1,321,988
733,421
1,025,046
1,518,607
0.18
25827.6
8
0.42
And
Northern
(Excludes
- 85 -
26
Hong Kong S.A.R.
1,006,590
2,049,374
3,814,266
4,177,629
2,930,264
0.17
-15.82
27
Israel
620,616
207,375
152,106
82,888
146,686
0.10
68.91
28
Argentina
530,500
232,959
199,984
177,813
95,550
0.09
60.69
29
Ireland
382,340
556,004
281,337
1,014,128
825,507
0.06
4.25
30
Colombia
290,215
6,188
118,354
0.05
-50.00
31
Kuwait
275,453
306
866
1,422
2,169
0.05
32
Norway
207,684
3,858
5,280
73
0.03
22444.7
8
1289.07
33
Portugal
173,930
127,229
0.03
34
India
118,115
113,374
1,666,329
658,794
55,472
0.02
287.88
35
Austria
110,400
121,695
202,990
0.02
-35.01
36
Venezuela
96,836
36,000
127,959
123,681
109,811
0.02
28.30
37
Guam
96,216
37,240
25,060
33,072
20,995
0.02
60.07
38
Vietnam
89,205
27,736
743
3,885
12,812
0.01
926.01
39
El Salvador
66,200
82,400
44,582
13,023
0.01
76.88
40
Mauritius
63,304
94,347
46,568
95,230
0.01
-46.00
41
Saudi Arabia
57,696
16,756
99,591
85,224
66,254
0.01
51.66
42
Nigeria
48,000
13,000
8,790
0.01
79.28
43
Barbados
47,606
0.01
44
Finland
42,065
26,521
19,361
0.01
-15.75
45
36,411
20,719
559,828
106,659
21,431
0.01
200.50
46
Hawaii
30,976
31,034
19,548
27,458
20,235
0.01
16.36
47
27,023
16,650
12,223
10,762
52,215
0.00
8.18
48
Uruguay
26,600
25,214
0.00
49
Turkey
21,750
9,000
9,198
10,783
0.00
31.20
50
Peru
20,670
11,540
8,300
9,353
0.00
4.54
51
Madagascar, Rep. Of
19,440
0.00
52
17,103
6,056
347,860
254,684
24,910
0.00
260.79
53
Switzerland
14,660
292
17,978
135
14,568
0.00
4485.03
54
Brunei Darussalam
11,160
2,132
1,596
640
25
0.00
766.60
55
Egypt
8,200
223,959
84,980
0.00
15.89
56
Trust Territory of Pac.ic Islands
6,635
10,163
36,961
58,608
5,915
0.00
186.67
57
Ecuador
6,000
12,000
0.00
58
Greece
5,610
158
173
379
0.00
-40.76
59
Bahrain
3,017
1,413
878
0.00
3.38
60
Aruba
1,948
0.00
61
Cambodia (Dem. Kampuchea)
1,660
665
0.00
62
Cyprus
1,652
25
376
0.00
1602.00
63
Czech Republic
1,650
39,600
142,454
0.00
-43.05
64
Lebanon
1,362
649
1,790
1,000
0.00
31.28
65
Sweden
918
649
0.00
- 86 -
66
Poland
630
128,944
330,844
0.00
-40.26
67
Qatar
538
627
1,188
183
128
0.00
132.68
68
Papua New Guinea
200
190
0.00
69
Oman
183
1,082
2,916
985
1,915
0.00
70
Alaska
11,408
0.00
71
Algeria
17,250
16,808
0.00
-50.00
72
Bangladesh
9,913
75,900
0.00
-46.73
73
Bermuda
598,402
0.00
74
Bhutan
29,500
0.00
75
Bulgaria
88,400
534
0.00
-50.00
76
Canary Islands
73,279
1,200
0.00
1476.65
77
Cape Verde
28,800
0.00
78
Cuba
205,600
62,593
0.00
79
Equatorial Guinea, Rep. Of
60,859
0.00
80
Guatemala
8,783
8,265
0.00
-50.00
81
Hungary
89,343
78,900
148,125
28,400
0.00
72.02
82
Iceland
2,448
0.00
83
Iran
8,050
6,325
22,413
0.00
-43.18
84
Jordan
14,250
0.00
0.00
85
Kenya
1,218
4,530
0.00
-50.00
86
Micronesia Federated States of
285
522
0.00
-50.00
87
Myanmar (Burma)
136,800
0.00
88
Nauru, Rep. Of
1,254
0.00
89
Nepal
27,500
0.00
90
Netherlands Antilles
41,600
0.00
91
Nicaragua
18,014
0.00
92
Palau, Rep. Of
170
292
0.00
93
Puerto Rico
41,712
0.00
94
Reunion
27,500
0.00
95
St. Helena
154
0.00
96
Syrian Arab Republic
1,072,700
0.00
97
Ukraine (Ukrainian S.S.R)
17,200
17,200
17,200
0.00
98
Zimbabwe
6,175
0.00
- 87 -
0.37
-50.00
-50.00
-25.00
- 88 -

ANNEX XIII
DIRECTORY OF CHAMBER OF FILIPINO DRUG MANUFACTURERS AND DISTRIBUTORS
(as of January 2004)
- 89 -
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
ASIAN ANTIBIOTICS, INC.

(M) 130 PIONEER STREET
MANDALUYONG CITY
zmreyes@unilab.com.ph
634-0912
634-0882
6340881
CLAUDERIA
C.
DE LEON
PLANT DIRECTOR
ALEJANDRO
M.
GARCIA
PRESIDENT
853-1005/851-4608
851-4690
845-5356
ASHFORD PHARMA. LABS, INC.

(M) 145 P. P. OLIVEROS ST.
ANTIPOLO CITY
658-3969
660-4095
6584298
GREGORIO
C.
DIZON
PRESIDENT
BASIC PHARMACEUTICAL CORP.

38 BARASOAIN, LITTLE BAGUIO
(D)
SAN JUAN,M.M.
724-0647 OR 2931
723-9942
7234159
7234151
TERESITA
T.
CHAN
PRESIDENT
631-6726
631-6726
JESUS LUIS
T.
ALDEA
PRESIDENT
722-4637
724-9319
7224915
MAIZE FRANCES
QUA
CHAIRMAN
8077695
8079675
8076303
8079735
7725102
GONZALO
C.
GALANG
VP & GEN.MGR.
ALMAN PHARMACEUTICALS, INC.

MLA. OFF: UNIT 1A PATRICIA BLDG.
(D)
1050 EDSA, MAGALLANES VILL. MAKATI CITY
- 90 -
basicpharm@mydestiny.net
BIO-STRATA PHARMACEUTICALS, INC.
101 SHAW BOULEVARD
(D)
PASIG CITY
biostrata@manila.online.net
BLOOMING FIELDS PHILS.,INC.
CROMWELL ROAD
(D)
CITY OF MANDALUYONG, M.M.
bfields@info.com.ph
BOIE, INCORPORATED
520 ALABANG-ZAPOTE ROAD
(D)
ALMANZA,REAL STREET
LAS PINAS,M.M.
boie@pacific.net.ph
Member Company
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
CISTRON PHILS., INC.

19 VICENTE RECTO STREET
(D)
807-4291
807-4247
ANTONIO
B.
PENALOZA
C.E.O.
932-7555
931-1843
931-1179
931-1838
diamond@I-manila.com.ph
633-7185 TO 86
932-7551
931-1826
932-9539
JASON
CABRERA
EXECUTIVE OFFICE
6337189
MA. LOURDES
B.
BUENSUCESO
PRESIDENT
PARANAQUE, M.M.
DIAMOND LABORATORIES, INC.
(M) 8 PERIA ROAD
COMMONWEALTH AVENUE
DILIMAN. QUEZON CITY
http://diamondlabs.com/home.html
ELIN PHARMACEUTICALS, INC.
(M) 10/F JMT CORPORATE CONDOMINIUM
ADB AVENUE, ORTIGAS CENTER, PASIG CITY
sales@elinpharma.com
WAREHOUSE
929-5367
- 91 -
FILADAMS PHARMA, INC.

37 MAPAGKUMBABA COR. MATIPID ST.
(D)
SIKATUNA VILLAGE, QUEZON CITY
filadams@mydestiny.net
922-2284 TO 88
921-0868
ARMI ENCARNITA
A.
BUAN
PURCHASING OFFICER
FORAMEN PRODUCTS CORP.

67 SCOUT FUENTEBELLA
(D)
QUEZON CITY
eurohchei@itextron.com
373-3966
373-3922
373-0585
MA. CRISTINA
PALOMARA
GEN. MANAGER
GENERAL DRUG & CHEM'L. CO., INC.

(M) 82 MAYFLOWER STREET
631-85.01 LOC 8808
631-6021
LEONARD
M.
BERBA
VP/GM MFG SUBS/AFFILIATES
842-7155 TO 58
842-0376
WILFREDO
C.
OREJOLA
PRESIDENT & C.E.O
781-1447
781-5835
731-4875
781-1979
PERSEVERANO
L.
CRUZ
PRESIDENT & G EN MGR.
MANDALUYONG CITY
GX INTERNATIONAL, INC.
8/F ALPAP II BLDG. TRADE ST.
(D)
COR INVESTMENT DRIVE
MADRIGAL BUSINESS PARK, AYALA
ALABANG, MUNTINLUPA, M.M.
www.gxonline.com
HEXAGON CHEMICAL CORP.
RM302 SGS FOUNDATION BLDG.
(D)
1335 G. ARANETA AVENUE, SMH
QUEZON CITY
hexagonchem@cyberlink.net.ph
740-7604
Member Company
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
HIZON LABORATORIES, INC.

(M) MKTG OFFICE:
29 QUEZON AVE., QUEZON CITY
PLANT:
ASSUMPTION ROAD
SUMULONG HIGHWAY, ANTIPOLO CITY
hizonlab@hizonlab.com
697-5933
697-5937
ANNALEE
H.
CARINGAL
EXEC.DIR.-BUS.MGT&ADMIN
INTEGRATED PHARMA., INC.

416 DASMARINAS STREET
(D)
BINONDO. MANILA
www.integrated.com.ph
241-8501 to 04
241-3846
KATHERYN
C.
TANTIANSU
VICE PRESIDENT
PRESIDENT
mcsotelo@integrated.com.ph
KAMIRE, INC.
429-C 2/F MIRANDA BLDG.
(D)
SHAW BOULEVARD
MANDALUYONG CITY
718-1188 TO 90
7182535
KATIPUNAN REY
P.
DELOS
JR
LARGEN MED, INC.

UNIT 202-203 METRO SQUARE BLDG.
D)
35 SCT. DE GUIA COR SCT. TUAZON STS.
BRGY. LAGING HANDA, QUEZON CITY
373-7054
373-7050
373-7520
angelrenoa@yahoo.com
373-7050
ROGEN
B.
REYES
PRESIDENT/CEO
LE JUMONT PHARMA., INC.

SUITE 502 5/F WEST TRADE CENTER BLDG.
(D)
132 WEST AVE., QUEZON CITY
lejumont@edsamail.com.ph
413-7247
373-4690 TO 91
3734691
ELNORE
B.
MONTANO
OPERATIONS MGR.
LEMA PHARMACEUTICALS, INC.

ROOM 201 MENCHAVEZ BLDG.
(D)
ESCARIO ST., CEBU CITY
032-255-5144
032-253-0181
032-253-0181
ALEJANDRO
M.
GARCIA
PRESIDENT
alman@mazcom.com
REYES,
- 92 -
Member Company
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
LLOYD LABORATORIES, INC.

(M) CORPORATE OFFICE:
UNIT 2205-A WEST TOWER, PHIL. STOCK
EXCHANGE CENTER BLDG. ORTIGAS CENTER
PASIG CITY
MFG. COMPLEX
10 LLOYD AVE., 1ST BULACAN INDUSTRIAL
CITY BO. TIKAY, MALOLOS , BULACAN
www.lloydlab.com/stats/
636-2992 TO 95
WAREHOUSE:
372-3984
636-3699
JESUS
R.
SOLOMON
PRESIDENT
044-7940159
044-794-0499
637-7596
SALVADOR
O.
RIVERA
C.E.O
634-4839
ROMEO
S.
DELAVIN
PRESIDENT
687-3529
687-3006
687-3375
CHRISTOPHER
M.
GONZALES
COMPANY PHARMACIST
MEDHAUS PHARMA, INC.

36-A MAIN AVENUE
(D)
CUBAO, QUEZON CITY
911-2067
911-5459
GAUDENCIO
M.
AQUINO
PRESIDENT & GM
MEDECIA MED, INC.

MOLAVE STREET, AGUAS SUBDIVISION
(D)
MANIBAAG, PORAK PAMPANGGA
(045) 963-4698
(045) 322-0846
JAIME
V.
CAPIL
PRESIDENT
MACROPHARMA CORPORATION
SUITE 3204-B, TEKTITE EAST TOWER
(D)
PHILIPPINES STOCK EXCHANGE CENTER
- 93 -
ORTIGAS CENTER, PASIG CITY

MARKET WORLD DISTRIBUTORS, CORP.
HEAD OFFICE: 3/F THE CENTERPOINT BLDG.
(D)
GARNET RD. COR. JULIA VARGAS AVE.
ORTIGAS CENTER PASIG CITY 1605
SALES & DISTRIBUTORS OFC.
146 PASIG BOULEVARD, BAGONG ILOG
PASIG CITY
MAXWELL BYRD SPECIALTY PHARMACEUTICALS &
PRODUCTS CORP.
UNIT E -510, 5/F EAST TOWER, PSE BLDG.
(D)
PSE CENTRE, EXCHANGE ROAD
maxwellbyrd@edsamail.com.ph
info@lloydlab.com
634-8790
634-8783
632-9070
HEAD OFFICE
634-4845 TO 46
DISTRIBUTION:
671-0890
671-2117
Member Company
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
MEDIC AID DISTRIBUTORS, INC.

202 ELCO BUILDING, E. RODRIGUEZ AVENUE
(D)
QUEZON CITY
723-0071 TO 76
LOC.120to122
410-3250
911-5071 TO 87
724-8639
AMADO
A.
NGKING
PRESIDENT & GM
911-6673
911-6654
VIVIAN
Q.
AZCONA
PRESIDENT
MERCURY DRUG CORPORATION

7 MERCURY AVENUE COR. E. R ODRIGUEZ JR.
(D)
AVENUE, BAGUMBAYAN, QUEZON CITY
- 94 -
www.mercurydrug.com
METROPOLITAN PHARMACEUTICAL PRODUCTS, INC.
2/F MENESES HOLDINGS BLDG.
(D)
G. PUYAT COR. C. ARAGON STS.
BF HOMES, SUCAT, PARANAQUE, M.M.
info@mercurydrug.com
8072782
807-9756
807-2113
RUDY
A.
VERANO
PRESIDENT/ C.E.O
metropolitanpharma@vasia.com
MT. SINAI SCIENTIFIC & PHARMACEUTICAL SUPPLY
CARILLO-SANSANO BLDG.
(D)
47-A ANNAPOLIS ST. CUBAO, Q.C.
www.metropolitanpharma.com
912-2123
912-2117
912-2119
DAVID
R.
SANSANO
PRESIDENT
NOVOMED, INC.
PROV'L: 3/F DYZON BLDG.
246 WIRELESS, MANDAUE CITY
MLA:
566 SHAW BLVD., MANDALUYONG CITY
novomed_island.com.ph
ONE PHARMA COMPANY, INC.
A. LIWANAG COR. G. DIAZ STS.
(D)
BFRV, CLASSI 1 LAS PINAS CITY
032-345-9147
032-422-5711
032-3459147
HECTOR
T.
ROSELLO
GENERAL MANAGER
871-2941 to 43
871-2537
872-4292
871-7399
DANILO
R.
OLANOSA
PRESIDENT & C.E.O.
1pharma@I-next.net
www.onepharma.com.ph
ORO LABORATORIES, INC.

(M) 370 QUEZON AVENUE, QUEZON CITY
712-4969
712-3556
712-3576
MARIETTA
G.
HOLMGREN
PRESIDENT
PAREN PHARMA, INC.

GROUND FLOOR IDM BLDG.
(D)
A55 ARMSTRONG AVENUE
PARANAQUE CITY
paren@edsamail.com.ph
822-34-11
822-3438
821-5022
ARTURO
L.
XAVIER
PRES.&
DIRECTOR
MANAGING
Member Company
Tel. No./s
Fax No.
Contact Person
First Name
MI Last Name
Position
PHAREX HEALTH CORPORATION
924-2158/70
924-2145
RANDOLFO
S.
DEL
NAT'L. SALES MANAGER
PHARMA DYNAMIC, INC.

PDI BUILDING, 71 MAYSILO STREET
(D)
MANDALUYONG CITY
532-2021 TO 23
534-8241
532-2024
JOSEPH MICHAEL
G.
MAGBAG
GENERAL MANAGER
PHARMA MEDICA, INC.

SUITE 1708, 17/F ANTEL GLOBAL CORPORATE
(D)
CENTER, JULIA VARGAS ST. COR
MERALCO AVE., ORTIGAS CENTER, PASIG CITY
687-07-06
687-0875
687-08-75
GELACIO
C.
CRUZ
PRESIDENT/C.O.B
371-0143
373-6240
3711428
371-0143
ALBERTO
A.
SANTILLANA
PRES. & C.E.O.
743-2880
743-7602
NILO
S.
VALENTE
GENRAL MANAGER
(049)5412391
(049)5412390
ILDEFONSO
C.
RAMOS
OPERATIONS OFFICER
637-6971 to 72
637-4907
637-6963
VILLAMOR
A.
CANDO
PRESIDENT
895-4357; 895-4358
890-2278
895-4358
MA. LUISA
C.
PARUNGAO
OPERATIONS MANAGER
(D)
ROSARIO
817 EDSA SOUTH TRIANGLE, QUEZON CITY

www.pascuallab.com
PHARMA NUTRIA N.A., INC.

2/F MARREN BLDG. 1157 QUEZON AVE
(D)
geljrcruz@yahoo.com
- 95 -
svmore@pacific.net
PHARMASPEC N.A., INC.
(D)
3RD FLOOR, HIZON BUILDING

29 QUEZON AVE., QUEZON CITY
PHILIPPINE HEALTH FOOD MFG. CORP

(M) STA.ROSA BUSSINES PARK
BARANGAY DON JOSE, STA. ROSA LAGUNA
pm_phfmi@skynet.net
DL746-8893
PROHEALTH PHARMA PHILS.,INC.

2603, 26/F EAST TOWER
(D)
PHIL. STOCK EXCHANGE CENTER
ORTIGAS CENTER, PASIG CITY 1600
cando@prohealth.com.ph/
http://www.prohealth.com.ph
PROSEL PHARMACEUTICALS, INC.

9724 PILILIA ST., SANTIAGO VILLAGE
(D)
MAKATI CITY
prosel_manila@pacific.net.ph
Member Company
Position
372-6639
loc19
RODOLFO
CALMA
MANAGING DIRECTOR
687-1472
687-1471
687-1471
SANG JE
SOK
PRESIDENT
813-2508, 8138579
8138508
MARCIANITO
M.
JISON
CHAIRMAN & PRESIDENT
373-6240
373-6242
371-1428
NILO
S.
VALENTE
PRESIDENT
533-9329
533-9740
533-9219
MICHAEL
FRANCIS
A.
DELA CRUZ
PRESIDENT
(046)-4165070 TO 72
spms@pacific.net.ph
(46)416-4680
241-8501to 04
241-8501 loc113
049-549-2372 or 73
241-3846
ROSALINA
D.
NOLASCO
SENIOR VICE PRESIDENT
JOSE RIZALDE
V.
LAVARRO
EXEC. VICE PRES.
Tel. No./s
Fax No.
RANDRIL INTERNATIONAL CO., INC.

SUITE 401 4/F CEDAR EXECUTIVE BLDG.
(D)
26 TIMOG AVE. COR SCOUT TOBIAS ST.
QUEZON CITY
randril@itextron.com
372-6637 to 39
RX CONSULTANTS, INC.
UNIT 809 PRESTIGE TOWER CONDOMINIUM
(D)
EMERAL AVENUE, ORTIGAS CENTER
PASIG CITY
B.
kupp@mindgate.net
SONIX PHARMACEUTICALS, INC.
PENTHOUSE, ACE BUILDING RADA, CORNER
(D)
DE LE ROSA ST. LEGASPI VILLAGE, MAKATI
- 96 -
mmjison@pworld.net.ph
S.V. MORE PHARMA CORPORATION (M.M.L.)
4/F MARREN BUILDING
1157 QUEZON AVENUE, QUEZON CITY
SYDENHAM LABORATORIES, INC.
(M) 566 SHAW BLVD. MANDALUYONG CITY
PLANT:
AGUINALDO HIWAY NR. GOVERNOR'S DRIVE
DASMARINAS, CAVITE
SWISS PHARMA RESEARCH LAB.
(M) 416 DASMARINAS ST., BINONDO, MANILA
PLANT: BARRIO PITTLAND
CABUYAO, LAGUNA
www.sprli.com
TECHNOMED INTERNATIONAL, INC.
4/F MEDECOR BLDG., ORTTIGAS AVENUE
(D)
GREENHILLS, SAN JUAN , M.M.
tecnomed@info.com.ph
373-6591
svpsprli@laguna.net
744-8646
721-1320
721-1860
049-549-7210
721-1850
Contact Person
First Name
MI Last Name
Member Company
Position
807-2111
TOMAS
VICTORINO
A.
MENESES
PRESIDENT
746-8892
VALENTIN
M.
CUSTODIO
MANAGER
634-5679
636-7774
636-5439
PATRICK
A.
YUSINGCHO
MARKETING MANAGER
VIRGO PHARMACEUTICAL, INC.

(M) 270 N.S. AMORANTO AVE.
STA . MESA HEIGHTS, QUEZON CITY
virgolab@skynet.net
740-1384
740-1385
741-5903
ROSALINDA
G.
VILLANUEVA
PRESIDENT
ZYLAN PHARMA, INC.

33 GERMANY STREET
(D)
BETTERLIVING SUBD. PARANAQUE CITY
zylan@mindgate.net
823-5662, 823-1104
824-4647
823-1104
ABELARDO
A.
AQUINO
PRESIDENT
Tel. No./s
Fax No.
TYNOR DRUG HOUSE, INC.

MENESES HOLDINGS BLDG.
(D)
G. PUYAT COR. C. ARAGON STREETS
BF COMM'L CENTER, SUCAT PARANAQUE,M.M.
807-2123 TO 25
tynor@skynet.ph
631-8501
LOC 5026
UNITED LABORATORIES, INC.

(M) 66 UNITED STREET
MANDALUYONG CITY
www.unilab.com.ph
VENUTEK MEDICA, INC.
3/F DISPOPHIL BLDG.
(D)
BLESSED JOSE MARIA ESCRIVA STREET
venutek@dispointernational.com
(M) MANUFACTURERS
(D) DISTRIBUTORS
- 97 -
Contact Person
First Name
MI Last Name
Member Company
- 98 -

ANNEX XIV
COMPANY/PRODUCT PROFILE FORMS
- 99 -
- 100 -
COMPANY / PRODUCT PROFILE FORM

AsiaHealthCare 2004 Buyers/Sellers Meeting on Pharmaceuticals and Natural Products
SINGAPORE 14-16 JULY 2004

Name and Title:
Isagani B. Ocampo Operations Manager
Company name
ACE PHARMACEUTICALS, INC.
Street - POB
101Don Vicente St., Kon Antonio Hts., Bgy. Holy Spirit
City - Country
Quezon City, Philippines
Email:
ibocampo14@hotmail.com
Tel: 632.931.0540
Fax: 632.427.2577
Year established: 1975
Number of employees: 130
Bank Ref: BPI, PNB
Website address of company:
Activities
Exporter Wholesaler/Retailer Manufacturer/Producer
Importer
Trader
Other: ______________
Countries previously imported/exported to:
Description (please give generic names and specify if the product is indigenous)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Anaesthetics:
General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation
Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease
modifying agents in rheumatoid disorders (DMARDs)
NSAIMs Opioid analgesics Used to treat gout DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific Specific
Anticonvulstants/antiepileptics:
Anti-infective medicines:
Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents
Antimigraine medicines:
For treatment of acute attack For prophylaxis
Antineoplastic, immunosuppressives and medicines used in palliative care:
Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicines Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes Plasma fractions fro specific use
Cardiovascular medicines:
Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering
Dermatological medicines (topical)
Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation
Scabicides/pediculicides Ultraviolet
Diagnostic agents:
Ophthalmic Radio contrast media
Disinfectants and antiseptics:
Antiseptics Disinfectants
Diuretics
Gastrointestinal medicines:
Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives
Used in diarrhea Antidiarrhoeal (symptomatic)
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents
Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines
Immunologicals:
Diagnostic agents Sera and immunoglobulins Vaccines
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
Ophthalmological preparations:
Anti-infective Anti-inflammatory Local anesthetics
Miotics and antiglaucoma Mydriatics
- 101 -
I*
E*
22.
23.
24.
25.
26.
Oxytocics and antioxytocics:

Oxytocics
Antioxytocics
Peritoneal dialysis solution
Psychotherapeutic medicines:
Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders
Medicines acting on the respiratory tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral Parenteral Miscellaneous
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals
Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal
Medicines containing whole plant material or as raw material for the isolation of active substances or extracts
Saps and extracts, tinctures, balsams, lacs, gums, resins and starches
Essential oils
Fatty oils, fats, waxes and their derivatives
Colouring agents
29.
30.
Natural ingredients for cosmetics

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Medicinal and aromatic plants
Seaweed and algae
31.
Vegetable saps and extracts

Lacs, natural gums, resins, gum-resins and balsams
Other vegetable saps and extracts
Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes

Peanut oil & its fractions
Coconut, palm kernel or babassu oil
Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil
Animal or vegetable fats and oils and their fractions
Waxes
Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
I* = Import,
- 102 -
E* = Export


Name and Title:
Ritchie C. Corpus General Manager
Company name
ALDRIZ CORPORATION
Street - POB
23 Alijis-Murcia Road
City - Country
Bacolod City, Negros Occidental, Philippines
Email:
aldriz_exec_23@yahoo.com
Tel: 6334.432.3270 / 6334.433.8139
Fax: 632.433.8133
Bank Ref:
www.aldriz.com
Activities
Other: Distributors / Marketing
Importer
Trader
1.
2.
3.
Anaesthetics:
4.

5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

Diagnostic agents:
Diuretics
Immunologicals:
- 103 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.

Plant
Extracts
Thickening Agents
30.
Vitamins
Proteins
Waxes
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 104 -
E* = Export


Name and Title:
Limuel Z. Razo
Company name
ASIAN ANTIBIOTICS, INC.
Street - POB
130 Pioneer St.
City - Country
Mandaluyong City, Philippines
Email: lzrazo@unilab.com.ph
Tel: 632.631.8501
Fax:
Bank Ref:
Activities
Exporter
Wholesaler/Retailer Manufacturer/Producer
Importer
Trader
Other: _____________
Countries previously imported/exported to: EUROPE, INDIA, CHINA, ITALY, GERMANY,

FRANCE
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
I*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 105 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 106 -
E* = Export


Name and Title:
Teresita T. Chan
Company name
BASIC PHAARMACEUTICAL CORP.
Street - POB
38 Barasoin St. Little Baguio
City - Country
San Juan, Metro Manila, Philippines
Email: ttc@mail.mydestiny.net
Tel: 632.723.9942 / 632.723.4159
Fax: 632.723.4151
Bank Ref: BPI / Metrobank
Basicpharma.mydestiny.net
Activities
Exporter
Wholesaler/Retailer
Manufacturer/Producer
Importer
Trader
Other: _______________
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
I*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 107 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 108 -
E* = Export


Name and Title:
Sheila Mae M. Velilla General Manager
Company name
BIOLINK PHARMA
Street - POB
Unit 1207 President Tower, 81 Timog Avenue
City - Country
Email:
biolinkpharma@pacific.net.ph
Tel: 632.411.4448
Fax: 632.413.5079
Year established:
Bank Ref: Metrobank, Union Bank
www.biolinkpharma.com
Activities
Exporter Wholesaler/Retailer
Manufacturer/Producer Importer
Trader
Other: ______________
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 109 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 110 -
E* = Export


Name and Title:
Paulo P. Mamangun, Jr. - President
Company name
COCONUT HAVEN PHILIPPINES, INC.
Street - POB
C837 Turin, BF Homes, International
City - Country
Las Pias, Philippines
Email:
info@coconuthaven.com
Tel: 632.826.7571
Fax: 632.826.7571
Bank Ref:
www.coconuthaven.com
Activities
Exporter
Importer
Trader
Other: ___________
Countries previously imported/exported to: U.S.A. (New York and New Jersey)
1.
2.
3.
4.
Anaesthetics:
5.
6.
Diagnostic agents:
Diuretics
Immunologicals:
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
- 111 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 112 -
E* = Export


Name and Title:
Ma. Carlita R. Doran - President
Company name
CRD HERBAL PRODUCTS
Street - POB
Lot 29 Blk. 54 Braceville St, Fairmont Park II, North Fairview
City - Country
Email:
crdherbal@pworld.net.ph
Tel: 632.938.1763
Fax: 632.938.7163
Year established:
Bank Ref: Metrobank
Activities
Exporter
Importer
Trader
Other: _____________
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 113 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Thickening
Agents
Vitamins
Other additives
Proteins
Perfumery oils
Waxes
Oils
Preservatives
Raw plant material
Seaweed and algae

31.

32.


Waxes
33.
34.
35.
Biotech
I* = Import,
- 114 -
E* = Export


Name and Title:
Marilou Buensuceso
Company name
E.L. LABORATORIES, INC.
Street - POB
109 North Main Ave., Laguna Technopark
City - Country
Laguna, Philippines
Email:
Tel: 6349.541.3222
Fax: 6349.541.3221
Bank Ref: Devt. Bank of the Phils.
Activities
Exporter
Wholesaler/Retailer Manufacturer/Producer Importer
Trader
Other: ___________
Countries previously imported/exported to: VIETNAM, SINGAPORE
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
I*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 115 -
Mydriatics
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
LOOKING FOR :
1. CLIENTS FOR TOLL MANUFACTURING
2. SUPPLIERS OF PACKAGING MATERIALS
Foil, Vials, Bottles
I* = Import,
* GMP
CONTRACT MANUFACTURER SPECIALIZING IN:
CEPHALOSPHORIN ORAL PRODUCTS
NON SENSITIZING ORAL & LIQUID PRODUCTS
SMALL VOLUME PARENTERALS
OPHTAHLMIC SOLUTIONS
- 116 -
E* = Export


Name and Title:
Virgilio V. Ecarma Chief Executive Officer
Company name
ECARMA HEALTH OPTIONS
Street - POB
259 Dona Soledad Extension, Better Living Subdivision
City - Country
Paraaque City, Philippines 1711
Email: ecarma@tri-isys.com
Tel: 632.824.5175 / 632.823.1480
Fax: 632.822.7045
Bank Ref: Equitable PCI Bank
www.ecarma.net
Activities
Exporter
Importer
Trader
Other: ______________
Countries previously imported/exported to: KENYA, UGAND, TANZANIA, JAPAN /

U.S.A, INDIA under process
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 117 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 118 -
E* = Export


Name and Title:
Marilou Buensuceso President
Company name
ELIN PHARMA INC.
Street - POB
10/F JMT Corporate Condominium, ADB Avenue, Ortigas Center
City - Country
Pasig City, Philippines
Email:
Tel: 632.633.7185
Fax: 632.633.7189
Bank Ref: BPI
Activities
Exporter
Wholesaler/Retailer
Manufacturer/Producer Importer Trader
Other: ___________
Countries previously imported to: (Raw Materials / Finished Products)

INDIA, CROATIA, SPAIN, CHINA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
I*
Anaesthetics:
E*
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 119 -
22.
23.
24.

27.
28.
25.
26.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 120 -
E* = Export


Name and Title:
Gelacio C. Cruz - President
Company name
GERGREG PHARMACEUTICAL CORPORATION
Street - POB
S1708 Antel Global Corporate Center, J. Vargas Ave., Ortigas Center
City - Country
Email:
Tel: 632.687.0706
Fax: 632.687.0875
Bank Ref: Metropolitan Bank & Trust Co.
Activities
Manufacturer/Producer
Importer Trader
Other: ______________
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 121 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 122 -
E* = Export


Name and Title:
Lucita Yu Soriano Exec. Director
Company name
HIZON LABORATORIES, INC.
Street - POB
Assumption Road, Sumulong Highway
City - Country
Antipolo City, Philippines
Email:
lysoriano@hizonlab.com
Tel: 632.697.5933
Fax: 632.697.5937
Number of employees: 500+
Bank Ref:
Activities
Exporter
Trader
Other: ___________
Countries previously imported/exported to: EUROPE, CHINA, INDIA, SINGAPORE
I*
E*
1.
Anaesthetics:

2.
3.
4.
5.
6.
7.
8.
9.
10.
11. Blood products and plasma substitutes:
12. Cardiovascular medicines:
Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipidlowering
13. Dermatological medicines (topical)
14. Diagnostic agents:
15. Disinfectants and antiseptics:
16.
17.
18.
19.
Diuretics
Immunologicals:
20.
21.
- 123 -
22.
23.
24.
25.
26.

27.
28.

Essential oils

Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Raw plant material

Seaweed and algae
31.
Oils


32.

Waxes
33.
34.
35.
Biotech
CONTRACT MANUFACTURING SERVICES
I* = Import,
LOOKING FOR SUPPLIERS OF:

1. CELLO FOIL
2. BLISTER FOIL
3. PVDC / PVC FILM
4. REFERENCE BOOKS FOR HERBAL MEDICINE AND TEST PROCEDURES
- 124 -
E* = Export


Name and Title:
Daisylinda S. Garcia General Manager
Company name
LAFAYETTE PHARMACEUTICAL LABORATORIES, INC.
Street - POB
132 13th Avenue, Cubao
City - Country
Email: info@lafayette.com.ph
Tel: 632.913.3724 / 632.911.7292
Fax: 632.913.3723
Number of employees: 150+
Bank Ref:
http://www. Lafayette.com.ph
Activities
Exporter
Importer Trader
Other: ______________
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 125 -
I*
E*
22.
23.

Oxytocics
Antioxytocics
27.
28.
24.
25.
26.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 126 -
E* = Export


Name and Title:
Nestor T. Mendoza Business Development Manager
Company name
LLOYD LABORATORIES, INC.
Street - POB
Unit 2205 A West Tower, Philippine Stock Exchange Center Building,
City - Country
Ortigas Center, Pasig City, Philippines
Email: info@lloydlab.com
Tel: 632.6362992 - 95
Fax: 632.636.3699
Bank Ref: BPI
www.lloydlab.com/stats
Activities
Exporter
Importer
Trader
Other: _____________
Countries previously imported/exported to: INDIA, SINGAPORE
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
I*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 127 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 128 -
E* = Export


Name and Title:
Ma. Lourdes Jalandoon - Pharmacist
Company name
MACROPHARMA CORPORATION
Street - POB
3204-B Tektite East Tower, Stock Exchange , Ortigas Center
City - Country
Email: dustine21@yahoo.com
Tel: 632.634.8790 / 632.632.9070
Fax: 632.637.7596
Bank Ref:
www.macropharma.com.ph
Activities
Exporter
Wholesaler/Retailer
Other: _____________
Countries previously imported/exported to: SOUTH KOREA, NAMDAEMUN-NO, CHUNG-IT,

SEOUL, KOREA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
I*
Anaesthetics:
Dermatological medicines (topical)PIROXICAM PATCH
Diagnostic agents:
Diuretics
Immunologicals: EPOETIN - 2
20.
21.
- 129 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
Vitamins and minerals HERBAL, GARLIC, HAWTHORN, LEMON BALM, GINKGO B.
28.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 130 -
E* = Export


Name and Title:
Cesar Mercado Exec. Vice President
Company name
MEDGEN LABORATORIES, INC.
Street - POB
74 Mindanao Avenue
City - Country
Email: medgen@textron.com
Tel: 632.456.0825
Fax: 632.920.0306
Bank Ref: Banco de Oro
Activities
Exporter
Trader
Other: ______________
Countries previously imported/exported to: AUSTRALIA
I*
1.
2.
Anaesthetics:
modifying agents in rheumatoid disorders (DMARDs) MEFENAMIC ACID

5.
6.
Anti-infective medicines: AMOXICILLIN, CHLORAMPHENICOL, PTERONIDAZOLE, CLOXACILLIN,
COTRIMOXAZOLE
7.
8.
3.
4.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Diagnostic agents:
Diuretics
Gastrointestinal medicines: CICYCLOVERINE
Immunologicals:
20.
21.
- 131 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 132 -
E* = Export


Name and Title:
Benson Sian General Manager
Company name
NATURAL QUALITY CORP.
Street - POB
No. 59 B.G. Belmonte ST., 2/F 88 Place, New Manila
City - Country
Email: nsaphil@vasia.com
Tel: 632.723.1828
Fax: 632.723.1798
Bank Ref:
www.natturalTM.com
Activities
Importer
Trader
Other: __________
Countries previously imported/exported to: MIDDLE EAST
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 133 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 134 -
E* = Export


Name and Title:
Arturo L. Xavier
Company name
PAREN PHARMA, INC.
Street - POB
G/F Agchem Bldg., 197 Doa Soledad Ave., Ext., Bicutan
City - Country
Paraaque City, Philippines
Email:
paren@edsamail.com.ph
Tel:
Fax: 632.821.5022
Year established:
Bank Ref: Metrobank
c/o CFDMD.org
Activities
Exporter
Wholesaler/Retailer
Other: _____________
Countries previously imported/exported to: INDIA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
I*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 135 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
Comments : all types of injectibles only

Antibiotics, antibacterials
Wants to source from ASEAN countries
I* = Import,
- 136 -
E* = Export


Name and Title:
Cecilia C. Sison Manager, Pharmaceuticals Department
Company name
PHILIPPINE INTERNATIONAL TRADING CORPORATION (attached

agency of the Department of Trade and Industry)
Street - POB
116 Tordesillas Street, Salcedo Village
City - Country
Makati City, Philipines
Email: pitcccin@info.com.ph
Tel: 632.892.1061
Fax: 632.892.2054/2021
Bank Ref: LBP, PNB
Activities
Exporter
Wholesaler/Retailer
Manufacturer/Producer Importer
Trader
Other: _______________
1.
2.
3.
4.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
E*
Anaesthetics:
5.
Anticonvulstants/antiepileptics: CARBAMAZEPINE, PHENYTOIN
6.
Anti-infective medicines: ALBENDAZOLE / COTRIMOXAZOLE/CIPROFLOXACIN/CEFALEXIN/COAMOCICLAV/
CEFUROXIME/CLINDAMYCYCIN
7.
8.
9.
10.
I*
Cardiovascular medicines: NIFEDIPINE/DILTIAZEM/ATENOLOL/METOPROLOL/GEMFIBROZIL
Diagnostic agents:
Diuretics
Gastrointestinal medicines: HYOSCINE/LOPERAMIDE
Immunologicals:
- 137 -
planned
planned
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
Psychotherapeutic medicines: HALOPERIDOL
Medicines acting on the respiratory tract TERBUTALINE SULFATE/SALBUTAMOL
27.
28.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 138 -
E* = Export


Name and Title:
Tess E. Santos - President
Company name
PROSOURCE INTERNATIONAL, INC.
Street - POB
Platinum 2000, 7 Annapolis, Greenhills
City - Country
San Juan, Metro Manila, Philippines
Email:
psource@compass.com.ph
Tel: 632.727.3768
Fax: 632.727.3766
Year established:
Bank Ref: Asia United Bank
Activities
Other: __________
Countries previously imported/exported to: U.S.A / U.S.A., SINGAPORE
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 139 -
I*
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
Vitamins and minerals GRAPE EXTRACT, SKIN TABLE
28.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Coconut, palm kernel or babassu oil VIRGIN COCONUT OIL, - INDEGENOUS

Waxes
33.
34.
35.
Biotech
I* = Import,
- 140 -
E* = Export


Name and Title:
Rommel dela Cruz Vice President / Operations Manager
Company name
RCC AMAZING TOUCH INTERNATIONAL, INC.
Street - POB
1-5 Teachers Bliss Condo 2, Balon Bato
City - Country
Email:
inquiry@rccamazingtouch.com
Tel: 632.366.7894
Fax: 632.366.7895
Year established:
Bank Ref: BPI
www.rccamazingtouch.com
Activities
Exporter
Importer Trader
Other: __________

MALAYSIA, SINGAPORE, USA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
I*
E*
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
- 141 -
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Thickening
Agents
Vitamins
Other additives
Proteins
Perfumery oils
Waxes
Oils
Preservatives
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
ANTI-VIRAL HERBAL CREAM PREPARATIONS
I* = Import,
- 142 -
E* = Export


Name and Title:
Go, Thelma Tobias General Manager
Company name
SCHEELE LABORATORIES PHILS., INC.
Street - POB
08 Lope de Guzman St.
City - Country
Valenzuela City, Philippines
Email: isg@pacific.net.ph
Tel: 632.293.7151 / 293.7152
Fax: 632.983.7929
Bank Ref:
Activities
Exporter
Importer
Trader
Other: _____________
Countries previously imported/exported to: Raw Materials only

CHINA, HONGKONG, SINGAPORE, ISRAEL, GERMANY
1.
2.
3.
4.
Anaesthetics:
I*
7.
8.
9.
10. Medicines affecting the blood:
11. Blood products and plasma substitutes:
12. Cardiovascular medicines:
Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipidlowering
13. Dermatological medicines (topical)
14. Diagnostic agents:
15. Disinfectants and antiseptics:
16. Diuretics
17. Gastrointestinal medicines:
18. Hormones, other endocrine medicines and contraceptives:
19. Immunologicals:
20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
5.
6.
Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 143 -
Mydriatics
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
LOOKING FOR :
SOURCES OF PACKAGING MATERIALS (CHEAPER) ALUMINUM FOIL / PVC / ALUMINUM CAPS
BOOKS ON HERBAL MEDICINES TECHNICAL SPECS / ANALYSIS, ETC.
CHEAPER SOURCE OF QUALITY PHARMACEUTICAL RAW MATERIALS
- 144 -
E* = Export


Name and Title:
Michael Francis A. Dela Cruz
Company name
SYDENHAM LABORATORIES, INC.
Street - POB
E. Aguinaldo Hi-way corner Governors Drive
City - Country
Dasmarias Cavite, Philippines
Email:
Tel: 6346.416.4678
Fax: 6346.529.8100
Bank Ref: Land Bank
Activities
Exporter
Importer
Trader
Other: _____________
I*
1.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
- 145 -
E*
22.
23.
24.
25.
26.

Oxytocics
Antioxytocics
27.
28.

Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
NOTE: WE IMPORT ACTIVE RAW MATERIAL THEN CONVERT IT TO TABLETS, CAPSULES, ETC. AND SELL
LOCALLY.
I* = Import,
- 146 -
E* = Export


Name and Title:
Racquel P. Villanueva AVP Manufacturing Operations
Company name
VIRGO PHARMACEUTICAL LABORATORY
Street - POB
17 Hernani St., Sta. Mesa Heights
City - Country
Quezon City, Philippines 1114
Email: virgolab@skyinet.net
Tel: 632.740.1384
Fax: 632.741.5903
Bank Ref: MBTC
Activities
Exporter
Importer
Trader
Other: _____________

CHINA, INDIA, SINGAPORE, HONGKONG, SPAIN, BULGARIA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Anaesthetics:
Diagnostic agents:
Diuretics
Immunologicals:
20.
21.
- 147 -
I*
E*
22.
23.
24.

27.
28.
25.
26.
Essential oils
Colouring agents
29.
30.

Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material

Seaweed and algae
31.

32.

Waxes
33.
34.
35.
Biotech
I* = Import,
- 148 -
E* = Export

20465651

Caricato da

Informazioni sul documento

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

20465651

Caricato da

Copyright:

Formati disponibili

SOUTH-SOUTH TRADE PROMOTION PROGRAMME

SUPPLY AND DEMAND SURVEY ON

Supply and demand survey on pharmaceuticals and natural products Philippines

Supply and demand survey on pharmaceuticals and natural products Philippines

SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS

Supply and demand survey on pharmaceuticals and natural products Philippines

RPs Top importers of pharmaceutical products (based on 2002 figures)

Product coverage for pharmaceutical products

Supply and demand survey on pharmaceuticals and natural products Philippines

Bureau of Food and Drug

Bureau of Trade Regulation and Consumer Protection

Chamber of Filipino Drug Manufacturers and Distributors, Inc.

Chamber of Herbal Industries of the Philippines

International Trade Centre

Income Tax Holiday

Overseas Filipino Workers

Pharmaceutical Healthcare Association of the Philippines, Inc.

Philippine Institute of Traditional and Alternative Health Care

Philippine International Trading Corporation

Philippine National Drug Formulary

Research and Development

United States Pharmacopoeia / National Formulary

Supply and demand survey on pharmaceuticals and natural products Philippines

Industry products and product classification

Supply and demand survey on pharmaceuticals and natural products Philippines

B. Objectives of the demand survey

To give an overview of the Philippine pharmaceutical and natural products market by

To identify companies which could be targeted as potential importers/buyers.

Qualitative industry data using past studies and existing reports.

Interviews with industry players and industry experts

Updating of companies contact information by telephone

Supply and demand survey on pharmaceuticals and natural products Philippines

SUMMARY OF CONCLUSIONS AND

New projects with pioneer status

six (6) years

Tax deduction for labor expense;

Tax credit on raw materials and supplies.

Employment of foreign nationals;

Simplification of custom procedures;

Importation of consigned equipment; and

Operation of bonded manufacturing/trading warehouse.

Supply and demand survey on pharmaceuticals and natural products Philippines

Supply and demand survey on pharmaceuticals and natural products Philippines

NOVARTIS Healthcare Phils.

Supply and demand survey on pharmaceuticals and natural products Philippines

Figures were given by industry players

Supply and demand survey on pharmaceuticals and natural products Philippines

The increase in ageing population, trend towards self-medication, emergence of unknown

The growing consciousness for environment-friendly products.

Lagundi (Vetex Negundo) for asthma, coughs and colds;

Supply and demand survey on pharmaceuticals and natural products Philippines

Supply and demand survey on pharmaceuticals and natural products Philippines

III. MAIN REPORT

Supply and demand survey on pharmaceuticals and natural products Philippines

Source : National Statistical Coordination Board

Table 3. Countrys health expenditure Per Capita

Supply and demand survey on pharmaceuticals and natural products Philippines

Table 4. Governments fiscal allocation for health

Source : National Statistical Coordination Board

They manufacture their own products.

They manufacture for third party companies or traders.

Supply and demand survey on pharmaceuticals and natural products Philippines

They are registered owners of drug products.

They subcontract the manufacture of such products to licensed manufacturers.